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A B S T R A C T
Fear is an emotion that serves as a driving factor in how organisms move through the world. In this review, we
discuss the current understandings of the subjective experience of fear and the related biological processes
involved in fear learning and memory. We first provide an overview of fear learning and memory in humans and
animal models, encompassing the neurocircuitry and molecular mechanisms, the influence of genetic and en-
vironmental factors, and how fear learning paradigms have contributed to treatments for fear-related disorders,
such as posttraumatic stress disorder. Current treatments as well as novel strategies, such as targeting the
perisynaptic environment and use of virtual reality, are addressed. We review research on the subjective ex-
perience of fear and the role of autobiographical memory in fear-related disorders. We also discuss the gaps in
our understanding of fear learning and memory, and the degree of consensus in the field. Lastly, the develop-
ment of linguistic tools for assessments and treatment of fear learning and memory disorders is discussed.
1. Background/introduction
This review is being undertaken as part of the ‘The Human
Affectome Project’, an initiative organized in 2016 by a non-profit or-
ganization called Neuroqualia. To launch the Human Affectome
Project, a workshop was organized in Halifax, Nova Scotia, on August 4
and 5, 2016. The project aims to produce a series of overarching re-
views that can summarize much of what is currently known about af-
fective neuroscience while simultaneously exploring the language that
we use to convey feelings and emotions. The goal of this project was to
address two related issues: (1) to develop a comprehensive and robust
functional model for emotions and feelings that can serve as a common
focal point for research in the field and to avoid inconsistent constructs
(Izard, 2007); and (2) to support the neurophysiological and anatomical
substrates in the brain corresponding to emotions (Panksepp, 2007)
rather than emotions being natural kinds (Orteny and Turner, 1990).
The project is comprised of twelve teams that are organized into a
taskforce that is focused on the development of a comprehensive and
integrated model of affect that can serve as a common focal point for
affective research in the future. To that end, our team was specifically
tasked to review the neuroscience research related to anxiety and fear
and the language that people use to express feelings that relate to an-
xiety and fear. We were further asked to consider whether or not the
feelings that people convey in language might inform the way we ap-
proach neuroscience research on these topics. We were also asked to
identify the relationships that exist between anxiety and fear and the
other areas of affective research within this special issue (i.e.,
Physiological, Social, the Self, Anticipatory, Actions, Attention,
Motivation, Anger, Sadness, Happiness, and Hedonics) and to sum-
marize future research needs.
The current review first provides an overview of fear learning and
memory in humans and animal models, including the neurocircuitry
and mechanisms involved, the role of genetic and environmental fac-
tors, the contribution of fear learning paradigms for treatments of fear
learning and memory disorders, as well as a discussion on the degree of
consensus and gaps of knowledge in the area of fear learning and
memory. In addition, the mechanisms of action of existing treatments
for posttraumatic stress disorder (PTSD) and development of novel
therapeutic strategies for PTSD, including those targeting the pre-
synaptic environment involved in fear learning and memory and those
involving virtual reality (VR) are discussed. Further, we discuss the role
of subjective experiences in fear, coding of fear memory as part of
autobiographical memory and autobiographical memories in fear-re-
lated disorders. Finally, the development of linguistic tools for assess-
ments and treatment of fear learning and memory disorders and how
they might be valuable for basic and translational purposes in the area
of fear learning and memory is discussed.
1.1. Definition of fear
Fear is defined as “a: an unpleasant often strong emotion caused by
anticipation or awareness of danger; b (1): an instance of this emotion;
(2): a state marked by this emotion” (Merriam-Webster, 2017). In line
with recent arguments by LeDoux and Hofmann (2018), here we re-
strict the use of the term ‘emotion’ to subjective experiences. In their
recent review, LeDoux and Hofmann refer to this view of fear as a
subjective emotional experience as the neuro-cognitive approach, in
which subjective fear emerges from higher-order processing. This view
in turn is based on arguments that emotional experiences are “cognitive
constructions based on conceptualizations of situations (Barrett, 2006,
2017; Barrett and Russell, 2015) or higher-order states that emerge as a
result of the cognitive integration in working memory of diverse
sources of information from within the brain and body (LeDoux, 1996,
2002; LeDoux, 2015a; LeDoux and Brown, 2017). LeDoux and Hofmann
further argue that verbal self-report of fear is the gold standard in as-
sessing conscious subjective emotional experiences including fear. As
such, since verbal self-report is not an option for non-human organisms,
determining whether non-human organisms have subjective experience
of fear is difficult (LeDoux and Hofmann, 2018). However, non-human
organisms do experience fear-related physiologic and behavioral states.
It is in this context that our understanding of the biological processes
involved has progressed most significantly over the last several decades.
1.2. The human emotion of fear
An organism's detection of potential threat involves innate biolo-
gical processes that exist across the phylogenetic evolutionary spectrum
(LeDoux, 2014). Much of what we have learned about how the human
brain processes threat has been learned from animal models in which
similar mechanisms operate (LeDoux, 1996). There are, however, im-
portant distinctions between the environmental detection of threat and
the conscious experience of human fear. Simply put, threat detection is
only one process within the complex emotional experience of fear,
worry, and anxiety that comprise human states of being (LeDoux,
2014). The human brain, with its developed higher cortical regions,
allows for the activation of threat detection systems and ultimately fear
and anxiety through both external and internal cues. External cues are
elements in the environment that can pose a threat to the health, in-
tegrity, and existence of an individual person (e.g., venomous insects
and animals, heights, or a social aggressor). Internal cues include bodily
states (e.g., arousal) in addition to the thoughts that are produced
through our cognitive abilities. In other words, as humans, our threat
detection systems and subsequent feelings extend beyond “is that
dangerous” into numerous “what if” scenarios that include potential
sources of harm (e.g., illness, bodily injury).
Threat detection and defensive response behaviors are typically
based on situation-specific factors such as the proximity, intensity,
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immediacy, and probability of an aversive outcome (Blanchard et al.,
1998; Diamond et al., 1999). For example, a rodent will freeze in its
cage when presented with a sound or light that has been previously
paired with an electric shock in the same cage (Davis, 1992). In this
experimental example, the proximity, intensity, immediacy, and prob-
ability of an ensuing shock and its associated pain are well controlled
and the behavior of the rodent is highly predictable (it will freeze in
defense or flee depending on the options made available). In other
words, the rodent will act in a manner consistent with what it has
previously learned. As humans, our perception of these four factors is
more complex and can be manipulated by internal and external cues as
previously described.
As defined by LeDoux, fear can be defined as a state that occurs
“when the sentient brain is aware that its personal well-being (physical,
mental, social, cultural, existential) is challenged or may be at some
point” (LeDoux, 2014, p. 2876). Human fear includes awareness that
danger is near or possible, and in many types of human fear this can
activate the basic threat detection systems (phobia, panic, heights). The
mammalian response to threat involves the recruitment of the auto-
nomic nervous system to alter physiological activity (e.g., breathing,
heart rate, blood pressure (Kapp et al., 1979; Schneiderman et al.,
1974)) and endocrine systems to activate hormone release (e.g., cor-
tisol, epinephrine (Yehuda and McEwen, 2004)). A common thread
between lower mammals and humans in this regard is that these sys-
tems are activated in order to increase the odds that the organism will
survive a threatening cue or situation (Fanselow and Lester, 1988;
LeDoux, 2012). One of the key discriminating factors between lower
mammals and humans is the activation of non-conscious threat detec-
tion systems and the very human conscious feelings of fear, anxiety, and
worry (for in-depth discussion see recent work by LeDoux (LeDoux,
2012, 2014). The experience of human fear as an emotion (as well as
the etiology and treatment of fear-based disorders) occurs as a result of
the complex interaction between the activation of basic threat detection
systems, memory storage and retrieval, and our own conscious aware-
ness. A primary clinical presentation of the factors described in the
preceding section occurs in the aftermath of an experienced traumatic
event and the associated long-term psychobiological consequences.
2. Human studies of fear learning and memory
2.1. Prefrontal cortical involvement in fear memory
Human neuroimaging studies represent a significant amount of re-
search conducted on fear learning and memory (for reviews see Fullana
et al., 2016; Gilmartin et al., 2014; LaBar and Cabeza, 2006). While at
times this research can offer disparate views of conceptualized “emo-
tion” and “cognitive” neural mechanisms, more recently, distributed
processing perspectives suggest that these concepts are not separable
(Pessoa et al., 2002; Pourtois et al., 2013). Therefore, we present the
brief and generalized view that fear memory is an interaction between
neural regions considered to be traditionally more involved in cognition
(i.e., the dorsal and ventral lateral PFC; DLPFC, VLPFC, respectively),
neural regions traditionally considered to be more involved in emotion
(i.e., the orbital frontal cortex and the ventral medial PFC; OFC, VMPFC,
respectively), as well as neural regions that span both concepts (ante-
rior cingulate cortex; ACC) (Fig. 1). It is implausible that any of these
regions act in isolation, but rather in concert to provide rich contextual
ensembles of fear memory. Because this brief overview concerns PFC
mechanisms of fear memory, the amygdala and hippocampus fall out-
side the scope of this section. However, the understanding and asso-
ciation of PFC regions involved in fear memory can be better viewed
from the standpoint of functional and anatomical connectivity with the
amygdalar/hippocampal complex. Specifically, much of PFC integra-
tion with fear memory relies on consensus that the proximal in-
stantiation of fear memory occurs by interaction between the amygdala
and hippocampus, beginning by the signaling of stimuli that are
associated with, or predictive of, fear, which induces long-term po-
tentiation (LTP) of amygdala–hippocampal circuits to upregulate en-
coding processes (LeDoux, 2003; McGaugh, 2004; Rogan et al., 1997).
Therefore, to illustrate the PFC's involvement with fear memory, we
provide a brief framework that outlines lateral PFC regions traditionally
examined in the cognitive domain and medial PFC regions, traditionally
examined either in the emotion domain or spanning both domains.
Lastly, we incorporate these domains to understand the integration
across the PFC during the acquisition of fear.
To begin, we first summarize research that outlines brain regions
that traditionally have been investigated using cognitive tasks or are
theoretically motivated by understanding cognitive processes, namely
Fig. 1. Lateral and medial reresentation of PFC regions involved in the in-
tegration of fear memory. DLPFC, dorsolateral prefrontal cortex (light blue);
VLPFC, ventrolateral prefrontal cortex (dark blue); ACC, anterior cingulate
cortex (green); OFC, orbitofrontal cortex (orange); VMPFC, ventromedial pre-
frontal cortex (orange); amygdalar–hippocampal complex (white). (For inter-
pretation of the references to color in this figure legend, the reader is referred to
the web version of this article.)
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memory and attention. Neuroimaging research indicates that lateral
PFC (LPFC) regions become more active and are predictive of re-
membering, and thus indicative of encoding, during episodic and se-
mantic memory operations (Buckner and Koutstaal, 1998; Gabrieli
et al., 1996; Reisberg and Heuer, 2004). Additionally, research in-
dicates that the DLPFC is likely engaged in maintaining working
memory representations used to guide goal driven behavior in a top-
down manner (Cohen et al., 1997; D’Esposito, 2001). Conversely, the
VLPFC may be more involved in communication between posterior
cortex for access to, and resolve interference between, competing se-
mantic representations (Buckner et al., 1995). Moreover, neuroimaging
work indicates that the LPFC is involved with the general allocation of
attention, including a dorsal attentional system (DLPFC and superior
parietal) that maintains goal representations of “what” and “where” to
attend, and a ventral system (VLPFC and inferior parietal) that detects
or monitors sensory representations consistent with goals to induce
further processing (Corbetta et al., 2008; Corbetta and Schulman,
2002). Lastly, success at either attention or memory tasks appears to
involve coordination between the more anterior regions of DLPFC and
VLPFC, suggestive of communication between the two systems to ac-
complish task related goals (Shulman et al., 2009). Taken together,
regardless of whether the processes under investigation are labeled
“memory” or “attention”, it is sufficient to say that both must interact
or are largely inseparable when considering subsequent acquisition of
information, hence memory relies on attention. Furthermore, within
the LPFC, there appears to be a segregation of processes between
higher-order goal representation regions (working memory main-
tenance, general attention) of the DLPFC and lower-order access to
sensory or semantic representations (monitoring, selection) held in
posterior cortex consistent with the VLPFC.
Turning to neuroimaging research conducted on learning and
memory during emotion processing indicates canonical memory/at-
tention LPFC neural mechanisms discussed above, as well as distinct
medial brain regions, most prominently the OFC and VMPFC.
Inconsistency surrounds the exact anatomical demarcation between the
OFC and VMPFC in neuroimaging literature and lies outside the scope
of this section. Therefore, we will generally refer to the orbital frontal
and ventral medial regions as OFC/VMPFC. Neuroimaging research
indicates that the OFC/VMPFC is consistently activated when affective
stimuli are presented during tasks that involve attention or memory
(Armony and Dolan, 2002; Perlstein et al., 2002; Pessoa, 2008). Spe-
cifically, a compendium of research indicates that the OFC/VMPFC is
sensitive to reward-prediction and the expectancy of appetitive and
aversive properties of stimuli (Hikosaka and Watanabe, 2000; Pessoa,
2008; Schneider and Brueckner, 2000). Facilitated by dense anatomical
connections with the nucleus accumbens/ventral striatum and the
amygdala, representing the mesolimbic dopamine pathway, the OFC/
VMPFC lies in a position to represent the reward and thus, affective
value of stimuli (Goldman-Rakic and Selemon, 1986). The OFC/VMPFC
has also been shown to connect to inferior regions of temporal cortex to
access semantic and sensory representations and maintains expectation
of reward (Summerfield and Egner, 2009). Moreover, due to its position
as the most anterior region in reward processing pathways, research
indicates that the OFC/VMPFC is activated to maintain the outcome of
reward and value prediction (Knutson and Cooper, 2005). Therefore, it
is likely that when a stimulus is evaluated for its reward or affective
value, the OFC/VMPFC receives and maintains information about the
prediction and its outcome, putatively for higher-order brain regions to
access and incorporate with current task/goal demands, and subse-
quently make adjustments (Pessoa, 2008; Ridderinkhof et al., 2004).
Spanning both cognitive and emotion domains, the ACC was first
associated with cognitive processes during the bourgeoning of neuroi-
maging (Botvinick et al., 1999; Kerns et al., 2004). However, through
extensive research it has been incorporated into models of emotion and
motivation for at least the last decade (Ochsner and Gross, 2005;
Rushworth et al., 2004; Vogt, 2005). General consensus suggests that
roughly dividing (anatomically and functionally) the ACC into rostral
and caudal regions, reflects its involvement in cognitive-emotion pro-
cesses, respectively (Bush et al., 2000). In general, the rostral ACC has
been linked to cognitive interference (i.e., conflict monitoring and re-
sponse conflict), which when high, is thought to signal the need for
increased cognitive control (Botvinick et al., 1999; Kerns et al., 2004).
The caudal ACC has been related to emotion related processes, such as
detecting emotional stimuli (Vuilleumier et al., 2001), and most pro-
minently in the control or down-regulation of emotion through its
subgenual connections with the amygdala (Drevets, 2001). Therefore, it
is likely that the more rostral regions of the ACC are involved in de-
tecting and resolving conflict of on-going goal related activity via
anatomical connections to the DLPFC, while caudal regions may be
sensitive to conflict arising from emotion or affective value of stimuli in
the environment, perhaps by modulation of affective circuits (e.g.,
amygdala).
Taken together, a general framework for fear memory, then in-
corporates the previously mentioned neural mechanisms to indicate the
interaction between cognition and emotion, as a seamless function.
Importantly, none of the brain regions are isolated to “emotion” or
“cognition” processes; rather, they exist on a continuum of integration
depending on their anatomical and functional connectivity. Putatively,
higher-order execution and allocation of top-down attention consistent
with goal representation is maintained by the DLPFC. Because of its
anterior-dorsal position, the DLPFC contains little anatomical connec-
tion with primary sensory processing regions (Mesulam, 1998).
Mesulam (1998), while the VLPFC, via anatomical connection with
posterior sensory cortex, is in position to monitor information in
memory or the environment through lower-order bottom-up processing
of such representations consistent with goal attainment (Pandya and
Yeterian, 1985; Simons and Spiers, 2003). Through anterior VLPFC-
DLPFC anatomical connections monitoring and alerting of sensory in-
formation is updated to select, attend and maintain relevant re-
presentations. Similarly, because the DLPFC contains little anatomical
connection with the amygdala (Phelps, 2006), reward/affective value is
integrated through more ventral pathways to the OFC/VMPFC through
its connection with the mesolimbic dopaminergic pathway (i.e., ventral
striatum, nucleus accumbens; Goldman-Rakic and Selemon, 1986). This
evaluative information can be thus maintained and transmitted through
anatomical connection to the ACC to signal saliency (Haber et al.,
2006), which subsequently can signal phasic shifts to up- or down-
regulate attention and goal maintenance via connections with the
DLPFC. Therefore, while the DLPFC may represent the most abstract,
higher-order goal representation, due to its lack of direct connectivity
with sensory cortex and regions that represent reward or affective
value, this information is integrated and conveyed via OFC/VMPFC and
the ACC, respectively. The convergence of these processes signals,
“what” and “where”, fear is represented in the environment, which
induces continued or up-regulated processing via connections with the
amygdalar-hippocampal complex for encoding.
Finally, all regions/circuits/pathways are integral to the ultimate
learning and memory of a fear stimulus or context. Top-down goal re-
presentation (e.g., be careful when moving in the dark) is held at the
highest level by the DLPFC, which increases general attention alloca-
tion to environmental contexts. The VLPFC thus monitors sensory re-
presentations for selection of attention and continued processing (e.g.,
is that a predator's shape?). While simultaneous reward or affective
valuation from the OFC/VMPFC (e.g., predatory shape is of high re-
ward) can be maintained and transmitted via the ACC (e.g., possible
threat in the environment) to increase top-down control or alter goal
representation (e.g., be careful, or run away). The consequence of this
cascade is that stimuli and contextual elements within the environment
will be more greatly attended to and encoded for future reliance.
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2.2. Human syndromes of impaired fear learning and memory
There are several human syndromes of impaired fear learning and
memory that are known for some time. One is the relative rare Kluver-
Bucy syndrome involving injury to both anterior temporal lobes
(Lanska, 2018). Among a lot of other symptoms, patients lack emotions
of fear. Patients with amygdala damage have impairments to recognize
and express emotions, including impairments to remember an emo-
tional event (Chau and Galvez, 2012). In nonhuman primates, amyg-
dala lesions were shown to alter the social hierarchy (Rosvold et al.,
1954). Los of dominance was also seen in violent prison inmates in
Japan following surgical removal of their amygdalae (Narabayashi,
1972).
Some concepts about fear learning and memory have also been
around for some time. About fifty years ago, the division of the
amygdala in a dorsomedial division involved in defensive mechanisms
following stimulation with the basolateral division playing an in-
hibitory role was already described (Fonberg, 1968). In addition, over
forty years ago, it was described that predation affects sleep patterns,
including sleep duration (Allison and Cicchetti, 1976).
2.3. Memory for positive and negative events
Over the past decades, there has been increased interest in under-
standing how individuals remember events that evoke affective reac-
tions, with many theories proposed to explain the often-complex effects
of emotion on memory. The vast majority of these theories have focused
on effects of the arousal elicited by the event—the psychophysiological
responses and subjective feeling of excitement or agitation—and have
emphasized the processes that unfold as the event is initially processed
and consolidated. These theories have led to many important insights as
to the effects of emotion on memory, including the often-focal effects of
arousal on memory, enhancing some aspects of memory while having
no benefit on others (see Table 1).
There is a smaller, yet consistent, literature that has revealed dif-
ferences in the ways that positive and negative events are remembered,
even when these events are associated with similar levels of arousal.
Behaviorally, negative events are often remembered more vividly (e.g.,
Dewhurst and Parry, 2000; Ochsner, 2000) and with more specific
detail (e.g., Holland and Kensinger, 2012; Kensinger and Schachter,
2008) than are positive events.
Most research examining the basis for these valence differences has
focused on encoding processes, revealing that sensory processing is
disproportionately enhanced during the encoding of negative in-
formation whereas conceptual processing is disproportionately engaged
during the encoding of positive information (e.g., Mickley Steinmetz
and Kensinger, 2009). More generally, negative affect is thought to
encourage an analytic focus on event-specific details (Storbeck and
Clore, 2005, 2011), perhaps enabling the individual to hone in on what
has gone wrong or on where a threat lies (Levine and Bluck, 2004). By
contrast, pleasure seems to encourage a broadening of attention
(Fredrickson, 2001) and a heuristic or conceptual mode of processing
(Clore et al., 2001; Levine and Edelstein, 2009), perhaps because with
no problem to be solved, creative processing can be prioritized (Bless
et al., 1996). Interestingly, despite age-related changes in memory for
positive relative to negative events (Mather, 2012), the increased sen-
sory specificity of negative relative to positive memories may remain
present across the adult lifespan (e.g., Holland and Kensinger, 2012;
Kensinger and Schachter, 2008; Kensinger et al., 2007).
Recent research has suggested that this sensory specificity of ne-
gative memories can be linked to the way that sensory processes are
brought on-line again at the moment of retrieval. Multiple studies have
shown greater activation in ventral visual processing streams during the
retrieval of negative as compared to positive memories (e.g.,
Markowitsch et al., 2003; Piefke et al., 2003). Importantly, these dif-
ferences can exist even if those events are cued by neutral content
(Bowen and Kensinger, 2016; Kark and Kensinger, 2015). In Kark and
Kensinger (2015), participants viewed negative, positive, and neutral
images from the International Affective Picture System (Lang et al.,
2008). Later, at retrieval, their memories for those images was cued
with relatively neutral black-and-white line-drawing outlines of those
images. Memory for negative stimuli was associated with greater re-
activation of the visual regions recruited during encoding than was
memory for positive or neutral stimuli, and this overlap was ad-
ditionally linked to memory confidence. Bowen and Kensinger (2016)
replicated these findings: participants studied neutral words in the
context of negative, positive, or neutral faces or scenes and their
memories were later cued with those neutral words. There was greater
reactivation within the ventral visual processing stream during the
successful retrieval of neutral words that had previously been studied in
negative contexts compared to positive or neutral contexts. Im-
portantly, there was no emotion present in the retrieval cues (all were
neutral words), and thus these valence differences in recapitulation
must have been related to differences in the brain states triggered by
Table 1
Prominent theories of emotional memory that focus on importance of arousal.
Theory Brief summary of theory
Encoding Automatic or rapid processing (Ohman, 1979;
Pourtois et al., 2013)
Arousing information is oriented toward automatically and benefits from rapid processing.
Prioritization of processing (Pessoa, 2005) Arousing information is more likely to be prioritized for processing than neutral
information.
Cue-Utilization Hypothesis (Easterbrook, 1959) As emotional arousal increases, there is a restriction in the range of cues that are used or
attended.
Encoding and post-encoding Post-Stimulus Elaboration (Christianson, 1992) Arousing information is elaborated and rehearsed.
Memory Trade-Offs; Weapon-Focus Effect (Barrett,
2006; Loftus et al., 1987)
Some aspects of an arousing event are remembered well, at the expense of other aspects.
Arousal Biased Competition (Mather and Sutherland,
2011)
Arousal creates a “winner-take-more” state, biasing processing toward the information that
gains high priority via bottom-up or top-down influences.
Mediation Theory of Emotional Memory
Enhancement (Talmi, 2013)
Arousal re-allocates attentional and organizational resources.
Emotional Binding (Yonelinas and Ritchey, 2015) Item-emotion binding by amygdala leads to slower forgetting than item-context binding by
hippocampus.
Storage Memory Modulation (McGaugh, 2000) Arousal activates the amygdala and engages adrenergic and cortisol systems to promote
memory storage.
Retrieval Response Bias (Dougal and Rotello, 2007) Arousal causes individuals to be more liberal in endorsing a memory.
Subjective Sense of Recollection (Phelps and Sharot,
2008)
Amygdala engagement during retrieval biases individuals to experience a sense of
recollection.
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the emotion during encoding. Using a partial least squares analysis of
that dataset, it was additionally revealed that there was a valence effect
at retrieval, which was one of the dominant patterns in the data (Bowen
and Kensinger, 2017), despite the fact that there was no emotion in-
herent in the retrieval cues.
These results place new emphasis on differences in the ways that
positive and negative events are retrieved. While there is no doubt that
emotion affects the way that events are experienced, encoded, and in-
itially consolidated (McGaugh, 2000; Murty et al., 2011), these results
demonstrate the importance of considering longer time-courses for the
effects of emotion on memory. Based on these results, a new model was
developed, Negative Emotional Valence Enhances Recapitulation, with
the mnemonic “NEVER Forget.” This model builds off of the evidence
that negative valence has effects on encoding, storage, and retrieval
(see Fig. 2) and emphasizes the importance of considering effects of
emotional valence that extend past the initial encoding episode to in-
fluence how sensory processes are integrated into emotional memory
networks.
3. Translational studies of fear learning and memory in humans
and animal models
3.1. Neurocircuitry involved in extinction of fear memory in rodents;
translational studies in humans
An inability to suppress inappropriate fear responses is the hallmark
of fear-based disorders, such as PTSD (Rauch et al., 2006; Rosen and
Schulkin, 1998). A common, empirically-validated approach to treat
PTSD is Prolonged Exposure Therapy (PE) (Foa, 2011), one component
of which involves repeated exposure to fear-linked cues to produce
“extinction” of fear (clinically referred to as exposure leading to de-
sensitization) and to prevent avoidance responses to these cues
(Hofmann, 2008). This exposure-based learning can be modeled in the
laboratory, in both animals and humans, using Pavlovian fear con-
ditioning models in which fear is first linked to a previously innocuous
cue (conditioned stimulus; CS) and then decreased by presenting the CS
alone (producing extinction). Unfortunately, one major limitation of
extinction is that it is a temporary phenomenon and extinguished fear
can re-emerge with the passage of time (spontaneous recovery), as a
result of a change in experimental context (renewal shift), or by ex-
posing subjects to an aversive unconditioned stimulus (US) after ex-
tinction (reinstatement effect) (Bouton, 2004; Bouton et al., 2006;
Hermans et al., 2006; LaBar and Phelps, 2005; Meyers and Davis, 2007;
Milad et al., 2005; Robbins, 1990; Vansteenwegen et al., 2005). To-
gether, these findings suggest that extinction is a new learning process,
and fear reduction results from an inhibition rather than an erasure of
the original fear memory (Bouton, 2002). Fear extinction and its recall
have become the prime translational neuroscience target for the treat-
ment of PTSD and other anxiety disorders (Graham and Milad, 2011;
Jovanovic and Ressler, 2010; Milad and Quirk, 2012).
Convergent evidence from rat and human work has elucidated that
discrete, yet anatomically and functionally interconnected, brain
structures are critical for extinction learning and the retention of ex-
tinction memory (Fig. 3). Critical brain regions include the amygdala,
ventromedial prefrontal cortex (VMPFC), and hippocampus (Amano
et al., 2010; Bouton et al., 2006; Corcoran et al., 2005; Davis and
Whalen, 2001; Kalisch et al., 2006; LeDoux, 2000; Meyers and Davis,
2007; Milad and Quirk, 2002; Milad et al., 2006b, 2007; Ochsner and
Gross, 2005; Pape and Pare, 2010; Pare et al., 2004; Phelps, 2004;
Quirk and Beer, 2006; Quirk et al., 2006, 2003; Quirk and Mueller,
2008). During fear acquisition, sensory information about the CS and
the aversive US converge at the amygdala and become associated,
yielding the fear memory. This memory is subsequently translated into
conditioned responses of fear (CRs) (Davis and Whalen, 2001; LeDoux,
2000). Of note, the amygdala may also be involved in extinction
learning (Amano et al., 2000; Pape and Pare, 2010). Indeed, functional
magnetic resonance imaging (fMRI) studies in humans have correlated
amygdala activation with fear CRs during conditioning (LaBar and
Phelps, 2005; Phelps, 2004; Phelps et al., 2001). Prefrontal brain re-
gions that interconnect with the amygdala, particularly the infralimbic
cortex in rats and the VMPFC, a homologous structure in humans, are
important for the retention and retrieval of extinction memories and
consequent attenuation of fear CRs perhaps via inhibition of amygdala
output neurons (Milad and Quirk, 2002; Ochsner and Gross, 2005;
Fig. 2. A novel model to represent the encoding and retrieval of positive and negative memories. This model highlights the importance of considering negative
valence during all stages of memory, and how negative emotions at any point may affect the memory's strength.
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Phelps, 2004; Quirk and Beer, 2006; Quirk et al., 2003; Quirk and
Mueller, 2008) (Fig. 3). In rats, infralimbic cells display robust CS-eli-
cited activity during extinction recall, which is inversely correlated
with spontaneous recovery of fear CRs (Milad and Quirk, 2002). Indeed,
artificial stimulation of infralimbic cells in rats during extinction
learning strengthens extinction memory and attenuates spontaneous
recovery of extinguished fear during subsequent tests of extinction re-
call (Milad and Quirk, 2002). In humans, VMPFC activation during
extinction recall and VMPFC thickness are both positively correlated
with the magnitude of extinction retention (Hartley et al., 2011; Milad
et al., 2005, 2007; Phelps et al., 2004). In addition, the magnitude of
task-dependent functional coupling between the amygdala and VMPFC
has been shown to be negatively correlated with intensity of subjective
reports of negative affect (Banks et al., 2007).
Activation of the hippocampus is also involved in recall of extinc-
tion learning and the hippocampus mediates the context-dependent
renewal of extinguished fear (Kalisch et al., 2006; Milad et al., 2007)
(Fig. 3). In rodents, temporary inactivation of the hippocampus prior to
extinction learning prevents the expression of fear extinction when
tested in either the extinction context or in a different context
(Corcoran et al., 2005). It has been hypothesized that the hippocampus
controls the context-dependent renewal of fear CRs by regulating ac-
tivity within the amygdala, either indirectly via projections to the
VMPFC (Hoover and Vertes, 2007) and/or through direct projections to
the amygdala (Henry et al., 2008). In humans, hippocampal activation
is associated with successful retrieval of extinction memory and is po-
sitively correlated with VMPFC activation during extinction recall in
humans (Kalisch et al., 2006; Milad et al., 2007). Interestingly, in-
creased functional connectivity between the amygdala and the hippo-
campus has been attributed to the persistence of memories for emo-
tionally arousing events in humans (Hamann et al., 1999; Kilpatrick
and Cahill, 2003a, 2003b; Murty et al., 2011; Phelps et al., 2004;
Ritchey et al., 2008).
More recently, the default mode network (DMN), an intrinsic con-
nectivity network anchored in the VMPFC and precuneus/posterior
cingulate cortex, has been implicated in fear extinction. One recent
fMRI study suggests that that the DMN, and particularly the VMPFC, is
activated by cues signaling safety, but not those signaling danger
(Marstaller et al., 2017). Further, in that study, activity in the DMN was
inversely correlated with activity in brain regions associated with the
expression of fear CRs (i.e., dorsal anterior cingulate cortex, insula), and
was positively correlated with self-rated positive affect evoked by cues
that signal safety. These findings have led to the hypothesis that the
DMN, and the VMPFC in particular, is involved in the contextualization
of safety memories and in determining the most adaptive response to
the present situation (e.g., fight or flight). Taken together, these sepa-
rate lines of convergent evidence suggest that how these regions in-
teract with one another may mediate the control, or lack thereof, of fear
CRs in humans.
Dysfunction in fear circuitry has been a consistent finding in PTSD
neuroimaging studies, and is thought to play a role in the maintenance
of trauma memories. In particular, many studies have shown amygdala
hyperactivity in PTSD in response to both trauma-related and unrelated
negative stimuli (Bryant et al., 2008; Driessen et al., 2004; Hendler
et al., 2003; Liberzon et al., 1999; Morey et al., 2009; Pissiota et al.,
2002; Protopopescu et al., 2005; Rauch et al., 2000; Shin et al., 1997,
2004a, 2005; Vermetten et al., 2007; Williams et al., 2006). Ex-
aggerated amygdala reactivity in patients with PTSD may be due, in
part, to insufficient top-down regulation from the VMPFC. Insufficient
VMPFC may, in turn, lead to hyperarousal and deficits in extinction
retention, as well as an impaired ability to suppress attention and re-
sponses to trauma-related stimuli (Liberzon and Phan, 2003; Pitman
et al., 2001; Rauch and Shin, 1997; Rauch et al., 1998). Consistent with
this notion, studies have shown that exaggerated amygdala reactivity is
associated with lower responses in the VMPFC across individuals with
PTSD (Shin et al., 2004a, 2005). Although less commonly implicated,
abnormal hippocampal function and diminished hippocampal volumes
in PTSD patients have been associated with deficits in contextual pro-
cessing, as well as memory impairments and neuroendocrine dysregu-
lation (Bonne et al., 2001; Bremner, 1999; Bremner et al., 2003; Shin
et al., 2004a, 2006, 2004b; Werner et al., 2009). Poor extinction recall
and VMPFC-hippocampal dysfunction displayed by patients with PTSD
could undermine the efficacy of the therapeutic effects of exposure
(Charney and Deutch, 1996; Foa, 2000; Milad et al., 2008, 2009; Orr
et al., 2000; Pitman et al., 2001; Rougemont-Bucking et al., 2011; van
Minnen and Hagenaars, 2002); evidence of aberrant activation in fear
circuitry in humans with PTSD indicates a mechanism that directly
impacts PE success, since treatment relies on activation of fears (Pitman
et al., 2001; Rougemont-Bucking et al., 2011; Milad et al., 2008).
Although PE is an effective first-line treatment for PTSD, approxi-
mately 20–30% of patients who have completed treatment continue to
have a PTSD diagnosis, and a slightly higher percentage (30–40%) fail
to achieve a stringent criterion for good end-state functioning (Foa
et al., 1999; Rothbaum et al., 2005). In addition, a significant subset of
patients fail to complete treatment (20.5%) (Hembree et al., 2003). An
Fig. 3. Fear extinction neural circuitry and functional brain model during recall
of extinction learning. Top. Brain regions involved in fear extinction include the
infralimbic cortex [rodents]/ventromedial prefrontal cortex [humans] (red),
hippocampus (green), and the amygdala (blue). Rodent and human anatomical
models were created using the Allen Mouse Brain Atlas (Lein et al., 2007) and
the Allen Human Brain Atlas (Hawrylycz et al., 2012), respectively. Bottom.
During fear acquisition, sensory information about the conditioned stimulus
(CS) and the aversive unconditioned stimulus (US) converge at the amygdala
and become associated, yielding the fear memory. The fear memory is then
subsequently translated into conditioned fear responses. Prefrontal brain re-
gions that interconnect with the amygdala, particularly the infralimbic cortex in
rats and the ventromedial prefrontal cortex, a homologous structure in humans,
are important for the retention and retrieval of extinction memories and con-
sequent attenuation of conditioned fear responses perhaps via inhibition of
amygdala output neurons. It has been hypothesized that the hippocampus
controls the context-dependent renewal of conditioned fear responses by reg-
ulating activity within the amygdala either indirectly via projections to the
infralimbic cortex/ventromedial prefrontal cortex and/or through direct pro-
jections to the amygdala. (For interpretation of the references to color in this
figure legend, the reader is referred to the web version of this article.)
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even smaller number of patients respond to first-line pharmacological
treatments, such as selective serotonin reuptake inhibitors (SSRIs)
(Stein et al., 2009, 2006). In 2007, the Institute of Medicine concluded
that little empirical evidence exists to support current pharmacological
treatment for PTSD; therefore, new treatments are desperately needed
(IOM, 2007). Enhancing the neural and neurochemical substrates of
inhibitory fear learning could solve this challenge and improve PTSD
treatment outcomes (Graham and Milad, 2011; Jovanovic and Ressler,
2010; Milad and Quirk, 2012).
Various adjuncts have proven their potential as “cognitive en-
hancer” via an enhancement of extinction learning and its consolidation
(for a review, see Kaplan and Moore, 2011). One of the first compounds
assessed for this role was D-cycloserine (DCS), which increases gluta-
mate function in the brain. Animal studies have demonstrated that
administration of DCS before or after extinction learning results in
better extinction memory recall when tested 24 h later (Richardson
et al., 2004; Walker et al., 2002). While initial clinical studies of DCS
reported some promise when coupled with exposure therapy sessions
(Hofmann et al., 2006; Ressler et al., 2004), some more recent findings
suggest that DCS may be ineffective or even more harmful by enhancing
reconsolidation of the fear memory rather than the extinction memory
(Bolkan and Lattal, 2014; Lee et al., 2006; Rothbaum et al., 2014).
Nonetheless, research on DCS has paved the way for examining other
neurobiological targets that may be more effective for augmenting the
learning that occurs during exposure-based therapies. One such pro-
mising system is the cannabinoid system. Animal studies have shown
that pharmacological inactivation of type 1 cannabinoid receptors
(CB1) blocks the consolidation of fear extinction, suggesting that CB1
receptor activation is critical for extinction learning and/or its later
recall (Reich et al., 2008). Pharmacological enhancement of cannabi-
noid signaling has shown promise in human studies as well (Das et al.,
2013; Rabinak et al., 2014, 2013). For example, a randomized double-
blind placebo-controlled, between-subjects design in healthy adults,
Rabinak and colleagues demonstrated than an acute dose of Δ9-tetra-
hydrocannibinol (THC), a CB1 receptor agonist, administered prior to
extinction learning increased neural activation of the hippocampus and
VMPFC during extinction recall, tested 24 h after extinction learning
(Rabinak et al., 2014). Another promising system is the estrogen
system. Studies in rodents show that increasing estrogen levels during
or immediately following extinction learning increases c-fos activity in
the infralimbic cortex, and decreases c-fos activity in the amygdala. In
line with these results, elevated endogenous or exogenous levels of
estrogen in women is associated with better extinction memory recall
(Zeidan et al., 2011; Graham and Milad, 2013).
3.2. Neural mechanisms involved in fear learning and memory; focus on the
role of serotonin in animal models and humans
In this section, we consider the role of important neuromodulators
of fear-related physiologic and behavioral states, with a focus on ser-
otonergic systems.
3.2.1. Serotonergic systems and neuromodulation of fear-related
physiologic and behavioral states
Serotonergic systems modulate a number of fear-related physiologic
and behavioral responses and states. In some cases, the role of ser-
otonergic systems on different fear-related behavioral responses is un-
equivocally opposite. For example, serotonergic systems are thought to
facilitate anxiety-like and fear-related behavioral responses, but, in
contrast, to inhibit escape or panic-like behavioral responses (Abrams
et al., 2004; Hale et al., 2012; Hale and Lowry, 2011; Hassell et al.,
2017; Lowry et al., 2008; Lowry and Hale, 2010; Zangrossi and Graeff,
2014). On the surface, opposing effects of serotonergic systems on
different fear-related behaviors should not be surprising as some fear-
related behaviors are mutually exclusive. For example, freezing beha-
vior, which is commonly observed during innate fear-related responses
to predators or other imminent threats, and which is commonly ob-
served in cue- or context-dependent models of Pavlovian fear con-
ditioning, is incompatible with panic- or escape-like behavioral re-
sponses. What is shared among all of the fear-related behavioral
responses and behavioral states is that they are considered defensive
behavioral responses (e.g., freezing, hiding, risk assessment, flight, and
defensive threat/attack), which are those behavioral responses ob-
served in the presence of a real or perceived threat (Blanchard and
Blanchard, 2008).
3.2.2. Serotonergic systems and innate fear-related responses
Rodents respond to the presence of a perceived threat, e.g., shock or
predator odor, with innate avoidance and freezing behavior (Silva
et al., 2016; Takahashi et al., 2005), or startle responses (Brocke et al.,
2006). Evidence suggests that these innate fear-related behavioral re-
sponses are modulated by serotonergic systems. Serotonergic neuro-
transmission is regulated by the sodium-dependent, high affinity, low
capacity, presynaptic serotonin transporter, encoded by the SLC6A4
gene. The serotonin transporter clears serotonin from the synapse,
consequently determining the duration and extent of serotonergic sy-
naptic neurotransmission (Blakely et al., 1994; Torres et al., 2003). In
humans, allelic variation in a 44-base pair insertion/deletion poly-
morphism in the serotonin transporter gene promoter region (5-HTT
gene-linked polymorphic region or 5-HTTLPR) results in long (l) and
short (s) variants. The s allele is associated with reduced transcriptional
efficacy, and, consequently, lower serotonin transporter expression,
leading to reductions in serotonin re-uptake and increased extracellular
serotonin concentrations (Greenberg et al., 1999). Studies of eye blink
startle responses revealed that carriers of the s allele responded with
greater startle responses relative to l/l homozygotes (Brocke et al.,
2006). These data suggest that serotonin may enhance innate fear-re-
lated startle responses. Consistent with these findings, the 5-HT re-
ceptor agonist meta-chlorophenylpiperazine (mCPP) dose dependently
increases acoustic startle responses in rats (Fox et al., 2008). Although
exposure to predator odor has been associated with increased serotonin
metabolism in the central nucleus of the amygdala, an important
mediator of fear-related behavioral responses (Hayley et al., 2001),
little is known about the functional role of serotonergic signaling in
control of innate freezing responses to predator odor or other threats.
Determining the role of serotonergic systems in innate fear responses
such as freezing behavior remains an important objective for future
studies.
3.2.3. Serotonergic systems and conditioned fear-related responses
There is a general consensus that the amygdala plays an important
role in the acquisition, storage, and expression of cued fear-related
behavioral responses, while the hippocampus plays an important role in
encoding the contextual environment and the prefrontal cortex plays an
important role in modulating the expression of fear-related behavioral
responses (for review, see Davis and Whalen, 2001; LeDoux, 2000). The
role of serotonergic signaling in the amygdala, with a focus on the
basolateral amygdala, on fear acquisition and fear expression in Pav-
lovian fear conditioning models has recently been reviewed (Bocchio
et al., 2016). Briefly, there is some evidence that serotonergic neurons
modulate basolateral amygdala circuits during fear conditioning, but
there is equivocal evidence for phasic, time-locked, activation of ser-
otonergic neurons by unconditioned and conditioned aversive cues
(Bocchio et al., 2016). Given that serotonergic neurons have an ana-
tomical and functional topographical organization (Imai et al., 1986),
electrophysiological recordings of identified serotonergic neurons that
project to the basolateral amygdala will be required to address this
question. Nevertheless, similar to the effects of allelic variation in the 5-
HTTLPR on innate fear responses, carriers of the s allele show enhanced
fear-potentiated startle, relative to l/l homozygotes (Klumpers et al.,
2012), suggesting that serotonin may enhance fear-potentiated startle
responses. Overall, the weight of the evidence from both human and
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non-human animal studies supports the hypothesis that serotonin acts
within the basolateral amygdala to enhance fear acquisition, and,
possibly, fear expression (Bocchio et al., 2016). Studies also support a
role for serotonergic signaling in control of fear extinction (Narayanan
et al., 2011). Future studies are required to fully elucidate the role of
serotonergic signaling in the basolateral amygdala and the extended
fear circuitry in fear acquisition, fear memory consolidation, fear ex-
pression, fear extinction, spontaneous recovery of fear, and reinstate-
ment of fear.
3.2.4. Serotonergic systems and risk-assessment or conflict anxiety-related
responses
Risk assessment or conflict anxiety-like behavior is a fear-related,
defensive behavior that involves a high level of uncertainty in relation
to aversive outcomes (Blanchard and Blanchard, 2008). In many cases,
anxiety-related behavioral responses are associated with conditions that
involve a conflict between approach and avoidance, in situations that
involve both potential rewarding outcomes and potential aversive
outcomes (Lowry and Hale, 2010; Gray, 1982). An example in humans
might be a high school junior asking a high school senior out on a date
to Prom. In such situations, there is clear potential for either a re-
warding or aversive outcome, creating a conflict and apprehension or
anticipatory anxiety that may lead to avoidance.
Studies in rodents have demonstrated that anxiogenic drugs, an-
xiety-related neuropeptides, and other anxiogenic stimuli increase ex-
pression of c-Fos, encoded by the immediate-early gene, FOS, within
serotonergic neurons located in the dorsomedial part of the dorsal
raphe nucleus, a region with dense projections to the basolateral
amygdala and anxiety- and fear-related circuitry (Abrams et al., 2004;
Hale et al., 2012; Hale and Lowry, 2011; Hassell et al., 2017; Lowry
et al., 2008, 2005; Lowry and Hale, 2010; Zangrossi and Graeff, 2014).
Pharmacologic, lesion, and other approaches are consistent with a role
for serotonin, acting via 5-HT2C receptors within the basolateral
amygdala, in facilitation of anxiety-related behavioral responses and
anxiety states (Lowry et al., 2005).
On the other hand, evidence suggests that serotonergic neurons in
the median raphe nucleus play a role in the resolution of anxiety- or
fear-related behavioral responses (Forster et al., 2006, 2008). Re-
cognizing this topographical specificity of anxiogenic stimuli on ser-
otonergic systems is important, as it suggests that understanding the
role of serotonergic systems in control of anxiety- and fear-related be-
havioral responses will require approaches that take into account this
high level of specificity (e.g., recordings from anatomically or func-
tionally identified subsets of serotonergic neurons).
3.2.5. Serotonergic systems and panic-related or escape responses
In stark contrast to the evidence that posits that serotonin projec-
tions originating from the dorsal raphe nucleus and projecting to the
basolateral amygdala enhance anxiety-like behavioral responses, there
is overwhelming evidence suggesting that serotonin projections origi-
nating from the dorsal raphe nucleus and projecting to the dorsal
periaqueductal gray inhibit escape or panic-like behavioral responses
via actions at 5-HT1A and 5-HT2A receptors (Hassell et al., 2017; Spiacci
et al., 2016; Zangrossi and Graeff, 2014). Consistent with these find-
ings, Tph2 mutant mice (Tph2−/−) respond with increased escape-like
behaviors to associative footshock (Waider et al., 2017). Recent studies
have demonstrated that escape responses in the presence of a looming
threat are under control of a retinoraphe projection originating from a
subset of retinal ganglion cells (RGCs). In this model, looming signals
transmitted by RGCs projecting to the dorsal raphe nucleus activate
local GABAergic neurons that in turn inhibit serotonergic neurons
(Huang et al., 2017). Inhibition of serotonergic neurons that tonically
inhibit escape behaviors would be expected to disinhibit escape beha-
viors and enable successful escape from threat. These findings highlight
the importance of understanding the complexity of serotonergic effects
on fear-related physiologic and behavioral responses when envisioning
novel therapeutic strategies for treatment of stress-, anxiety-, and
trauma-related disorders.
3.2.6. Serotonergic systems and defensive threat/attack responses
Very little is known about the effects of serotonergic signaling on
defensive threat/attack responses in the presence of a perceived threat.
However, this promises to be a fruitful area for future research as
blockade of 5-HT2C receptors within the medial hypothalamus or dorsal
periaqueductal gray, critical structures involved in defensive threat
behaviors (Keay and Bandler, 2010), prevents stimulated defensive
threat responses (Bhatt et al., 2008; Hassanain et al., 2003a, 2003b).
3.2.7. Serotonergic systems and stress-induced enhancement of fear-related
responses
In addition to the role of serotonergic signaling in modulation of
fear-related physiologic and behavioral responses described above,
serotonin is also critical in stress-induced enhancement of fear-related
physiologic and behavioral responses, for example in a model of
learned helplessness (Maier and Watkins, 2005). This effect is thought
to be dependent on desensitization of inhibitory 5-HT1A autoreceptors
that normally inhibit serotonergic neuronal firing within the anxiety-
and fear-related dorsomedial part of the dorsal raphe nucleus (Maier
and Watkins, 2005; Rozeske et al., 2011). Thus, serotonergic systems
may play a role in normal, adaptive fear-related physiologic and be-
havioral responses, and also stress-induced exaggeration of these re-
sponses.
3.2.8. Serotonergic systems and stress-, anxiety-, and trauma-related
disorders
With a life-time prevalence of up to 20% of the population, stress-,
anxiety-, and trauma-related disorders, including PTSD, are common
and represent a significant social and economic burden (Kessler et al.,
1995, 2005a; Wittchen et al., 2011). A major risk factor for the de-
velopment of trauma-related and anxiety disorders is exposure to
stressful life events (Pemberton and Fuller Tyszkiewicz, 2016; Zavos
et al., 2012). One mechanism through which adverse events may affect
risk for stress-related psychiatric disorders is through effects on brain-
stem serotonergic systems (Valentino and Commons, 2005). These ef-
fects might involve the role of serotonin in sleep, including serotonin
release during slow-wave sleep (Lapierre et al., 2013), and the circadian
rhythms of sleep-wake cycles (Makamaru-Osigo, 2012). Further char-
acterization of the role of serotonergic systems in control of fear-related
physiologic and behavioral responses, and stress-induced exaggeration
of these responses, should enable development of novel therapeutic
strategies for the prevention and treatment of stress-, anxiety-, and
trauma-related disorders that involve dysregulation of fear.
3.3. Neural mechanisms involved in fear conditioning and extinction; focus
on the role of norepinephrine in animal models and humans
The locus coeruleus (LC) is a is a bilateral brainstem nucleus that is
the main source of norepinephrine (NE) projections within the central
nervous system (Aston-Jones and Waterhouse, 2016). It is also the
primary source of cortical NE (Giustino and Maren, 2018) and highly
relevant for fear and learning because of the many LC projections
(Schwarz and Luo, 2015; Schwarz et al., 2015) that extend to the
medial prefrontal cortex, the basolateral amygdala (all nuclei), the
central amygdala and the hippocampus (Foote et al., 1983). Locus
coeruleus norepinephrine (LC-NE) plays an important role in the for-
mation and retrieval of emotional memories (Raio and Phelps, 2015;
Rodrigues et al., 2009), a topic that we discuss below.
3.3.1. Noradrenergic systems and neuromodulation of fear-conditioning
The LC is active in response to both appetitive and aversive stimuli
(Foote et al., 1983; Zhang et al., 2014a). Several studies show that LC-
NE is important for cued fear conditioning (c.f., Uematsu et al., 2017).
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Decreasing NE with clonidine results in dose-dependent reductions in
fear expression while increases in NE (with piperoxane or yohimbine)
increase fear expression (Davis et al., 1979; Schulz et al., 2002). Under
high levels of stress, increased LC-NE produces corresponding increases
in amygdalar NE which promotes cued fear learning by enhancing
amygdala function and blunting prefrontal function, but under low le-
vels of arousal, the LC-NE promotes PFC function while inhibiting the
amygdala and promoting the extinction of cued fear (Arnsten, 2015;
Giustino and Maren, 2018).
Notably, the central amygdala is reciprocally connected to the LC
(Van Bockstaele et al., 1998) and it activates the LC via corticotropin-
releasing hormone under stress (Prouty et al., 2017). Since the central
amygdala is important for fear expression and involved in freezing
behaviors (via the periaqueductal gray) (Fadok et al., 2017; Haubensak
et al., 2010), this feedback loop appears to be a way to generate sus-
tained fear responses, especially after fear conditioning (Giustino and
Maren, 2018).
There is also some evidence to suggest that LC-NE may be important
for contextual fear learning as well. For example, the depletion of NE
results in impaired contextual fear (Hott et al., 2012; Murchison et al.,
2011; Onaka et al., 1996) while increased levels of NE promote con-
textual fear learning (Hu et al., 2007; Kim et al., 1997). But a recent
study has shown that reduced NE in the central amygdala reduces the
acquisition of context fear (Holmes et al., 2017) so the precise role of
NE in contextual fear learning is still not fully understood.
The hippocampus integrates spatial information which is also im-
portant in context fear conditioning (Maren et al., 2013). The hippo-
campus is also densely populated with β-adrenoceptors which regulate
long-term potentiation when activated by NE. In general terms, lower
levels of NE appear to facilitate memory retrieval while higher levels
promote long-term episodic memory (Harley, 2007). It is therefore
believed that long term potentiation in the hippocampus is modulated
by variations in NE (Lim et al., 2017) and that it is important for
contextual fear acquisition.
3.3.2. Noradrenergic systems and fear expression
NE is also involved in the modulation of fear expression as well.
Early studies with rodents revealed that experimentally decreasing NE
could produce dose-dependent reductions in fear expression whereas
increases in NE could produce corresponding increases in fear expres-
sion (Davis et al., 1979; Schulz et al., 2002). Some studies using single
shock conditioning have not produced consistent results (i.e., reduced
NE has had no effect), but it was recently discovered blocking NE
transmission disrupts multi-trial, but does not disrupt single-shock,
conditioning (Diaz-Mataix et al., 2017). Similarly, NE levels impact
contextual fear expression as well. Reducing NE produces deficits in
context fear retrieval (Murchison et al., 2011, 2004) whereas increases
in NE enhance context fear expression (Inoue et al., 2006).
3.3.3. Noradrenergic systems and memory
While NE is involved in the formation of cued fear memories
(Uematsu et al., 2017) it may not be critical for consolidation of such
memories. Research has shown that mice lacking NE do not have def-
icits in cued fear memory consolidation (Murchison et al., 2004;
Ouyang and Thomas, 2005) and manipulations (reductions) of NE in
the medial prefrontal cortex (Fitzgerald et al., 2015) and basolateral
amygdala (Bush et al., 2010) also have no apparent impact on fear
memory consolidation (Giustino et al., 2017). On the other hand, NE
appears to be centrally involved in contextual fear memory consolida-
tion. Increased NE enhances contextual fear memory consolidation, an
effect that can be reversed by blocking NE with propranolol (Gazarini
et al., 2013, 2014).
Reactivated memory has been shown to be a flexible state (Nader
et al., 2000), and within this process, NE also has a role to play in
memory reconsolidation (for both cued and contextual fear memories).
For example, reduced NE has been shown to disrupt memory
reconsolidation of both cued and contextual fear memories in rodents
(Debiec and LeDoux, 2004; Gamache et al., 2012; Przybyslawski et al.,
1999).
3.3.4. Noradrenergic systems and fear extinction
The hippocampus, basolateral amygdala and ventromedial pre-
frontal cortex all participate in the extinction of inhibitory avoidance
and contextual fear conditioning (Fiorenza et al., 2012). It is also
generally believed that stress-related increases in NE impair cued fear
extinction (Debiec et al., 2011; Giustino et al., 2016; Rosa et al., 2014).
For example, studies have shown that reduced NE impairs delayed fear
extinction (Fitzgerald et al., 2015; Mueller et al., 2008) and increased
NE enables delayed fear extinction (Debiec et al., 2011; Mueller et al.,
2009).
NE also has an important role in contextual fear extinction as well,
an action that appears to be reliant upon hippocampal function.
Blocking norepinephrine transporter enhances the extinction of con-
textual fear in a dose-dependent manner (Abraham et al., 2012)
whereas reduced NE has been shown to impair the extinction of con-
textual conditioned fear responses (Bernardi and Lattal, 2010; Do-
Monte et al., 2010).
3.3.5. Noradrenergic systems and stress-, anxiety-, and trauma-related
disorders
Increases in NE and corticotropin-releasing hormone (CRH) are a
well-established aspect of the stress response. CRH projections from the
central amygdala promote LC-NE activity during stress, which in turn
evokes acute anxiety responses as well as place aversion (Sun et al.,
2015). This, combined with the fact that many LC projections (Schwarz
and Luo, 2015; Schwarz et al., 2015) extend to the medial prefrontal
cortex, the basolateral amygdala, the central amygdala and the hippo-
campus (Foote et al., 1983), and the fact that locus coeruleus nor-
epinephrine (LC-NE) plays an important role in the formation and re-
trieval of emotional memories (Raio and Phelps, 2015; Rodrigues et al.,
2009) make it highly relevant for PTSD. Increases in the noradrenergic
signaling have been implicated in PTSD (Hendrickson et al., 2018;
Naegeli et al., 2018) and persistent changes in LC function have been
observed following stress/trauma (Blanchard et al., 2012; George et al.,
2013). These increases in NE are believed to support a “hypercondi-
tioning” response to fearful stimuli while also supporting a general
impairment in fear extinction (Norrholm et al., 2015; VanElzakker
et al., 2014).
3.4. Emotional olfactory fear memory during development and adulthood;
animal models
3.4.1. Olfaction: particularities and advantages for studying memory and
emotions
Olfactory stimuli are of prime importance throughout the life of
both human and non-human mammals. They regulate ethologically
vital behaviors such as feeding (reviewed in Palouzier-Paulignan et al.,
2012), orientation of the infant toward its caregiver (Al Ain et al., 2014;
Coureaud et al., 2010; Varendi and Porter, 2001), maternal behavior
(Corona and Levy, 2015; Lundstrom et al., 2013; Schaal et al., 1995), or
choice of a mating partner (Brennan et al., 1990; Edwards et al., 1990).
Supporting this pivotal role from very early infancy to adulthood, the
olfactory sensory system becomes functional in utero, thus ensuring the
transition between prenatal and postnatal environments (Mennella
et al., 2001; Pedersen and Blass, 1982; Schaal et al., 1998). This is
particularly important for rodent pups that are born blind, deaf and
hairless, and are critically dependent on odor cues to approach their
mother and attach to her nipples to get food and warmth.
The olfactory sensory pathways present a unique organization
among the sensory systems. Indeed, the olfactory bulb, first relay of
olfactory information, sends direct projections to the olfactory cortex,
without a thalamic relay (Haberly and Price, 1977). In parallel, the
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olfactory bulb sends dense projections to the cortical amygdala nuclei,
which project to the deeper basolateral nucleus (McDonald, 1998;
Savander et al., 1996). In addition, the olfactory bulb also makes
monosynaptic contacts with the lateral entorhinal cortex, which pro-
jects to the hippocampus (Witter and Amaral, 1991). This anatomical
organization illustrates that olfactory information has a unique rapid
access to two structures critically involved in emotion and memory, i.e.
the amygdala and hippocampus.
The vast majority of studies devoted to investigate the neural cir-
cuits of emotional memory in animals have used cued fear conditioning
that involves pairing an initially neutral tone with a mild footshock.
After a few such pairings, the animal develops a conditioned fear re-
sponse to the tone itself. Fear conditioning has been abundantly used in
adult rodents to investigate the neurobiology of learning and memory
and there is a broad consensus in this literature that the amygdala plays
a crucial role in the acquisition, storage and expression of cued fear
memories, while the hippocampus is involved in encoding the con-
textual environment, and the prefrontal cortex in modulating the ex-
pression of fear responses (for reviews see: Davis, 1992; LeDoux, 2000;
Maren, 2001). A main advantage of cued fear conditioning paradigm is
that it can also be applied to infants because it makes very little demand
on the animal's motoric capabilities. Since newborn rodents are blind
and deaf but perform very well with odors, odor fear conditioning
provides a unique opportunity to highlight differences in the formation
and expression of olfactory emotional memories through development.
3.4.2. Odor-shock conditioning from the early neonatal period to
adulthood: from odor preference to odor fear
Although the olfactory system becomes functional during the latest
stages of pregnancy, it continues to mature postnatally. For example, in
rodents the olfactory bulb's volume increases 7 times during the first 30
days, as it acquires the majority of its inhibitory interneurons (Rosselli-
Austin and Altman, 1979). Similarly, in the first days of life, the
amygdala is quite immature and different studies have shown profound
morphological and physiological changes during the first postnatal
month (Berdel et al., 1997; Chareyron et al., 2012; Ehrlich et al., 2012;
Ryan et al., 2016) followed by dendritic remodeling at adolescence
(Koss et al., 2014). The hippocampus and prefrontal cortex also exhibit
delayed morphological (Crain et al., 1973; Verwer et al., 1996) and
physiological (Bekenstein and Lothman, 1991; Nair et al., 2001; Nurse
and Lacaille, 1999; Swann et al., 1990) developmental profiles and
their maturation continues through adolescence (Dumas, 2005; Tarazi
and Baldessarini, 2000; van Eden et al., 1990).
This protracted development of the brain suggests the rodent neo-
nate has a unique circuitry for odor processing and learning that is
relevant to the continuously changing ecological context throughout
development. During their first two weeks of life, rodent pups are
mostly confined to the nest and strongly depend on their functional
olfaction to get access to milk, warmth and maternal care.
Consequently, at this developmental age, infant rodents exhibit strong
odor preference learning abilities presumably allowing them to attach
to their caregiver for survival (Cheslock et al., 2000; Sullivan et al.,
1989). Interestingly, in rat pups under 10 days of age, learned pre-
ference is also observed even when the odor is paired with a painful
stimulus such as tail pinch or mild electric footshocks (Camp and Rudy,
1988; Sullivan et al., 2000a). Thus, the same procedure that induces
learned odor fear in adult rats (i.e., odor-shock pairing) produces odor
preference in infant rats. This seemingly paradoxical pain-associated
preference is supported by neurobiological mechanisms that ultimately
promote preference regardless of the quality of parental care, thus en-
suring attachment to the caregiver (Boulanger Bertolus et al., 2016;
Perry et al., 2017; Raineki et al., 2010). Specifically, these mechanisms
involve plastic changes in the olfactory bulb and anterior piriform
cortex (Morrison et al., 2013; Roth and Sullivan, 2005; Sullivan and
Leon, 1986; Wilson et al., 1987; Yuan et al., 2002). In the olfactory
bulb, these changes are allowed by unique characteristics of infants’
locus coeruleus functioning, resulting in the release of high amounts of
norepinephrine (Nakamura et al., 1987) that are both necessary and
sufficient to produce learned odor preference (Sullivan et al., 2000b,
1992; Yuan et al., 2002). In rat pups under 10 days of age, the amygdala
Fig. 4. Main behavioral and neurobiological
characteristics of odor fear conditioning
through development. Left panel. In infant rat
pups under the age of postnatal (PN) day 10,
odor-shock training induces a learned odor
preference and involves a neural circuit in-
cluding the olfactory bulb and the anterior
piriform cortex with a unique functioning of
the locus coeruleus resulting in the release of
high amounts of norepinephrine (involved
brain regions and unique input of locus coer-
uleus on the olfactory bulb indicated in green).
Middle panel. From the age of PN10, odor-
shock training induces adult-like learned odor
fear that is sustained by a circuit involving the
amygdala and the posterior piriform cortex
(involved brain regions indicated in purple).
Right panel. As the pup grows older and reaches
adolescence and adulthood, other structures
mature and can modulate the learning such as
the prefrontal cortex and the hippocampus
progressively mature and are able to modulate
the learning (involved brain areas indicated in
pink). Besides resulting in odor preference,
early life odor-shock stressful experience also
induces emotional deficits throughout devel-
opment that can be rescued by the odor
learned during the neonatal period (for details,
see main text). (For interpretation of the re-
ferences to color in this figure legend, the
reader is referred to the web version of this
article.)
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is not recruited by the odor-shock association learning. This period of
life is characterized by reduced corticosterone and ACTH release in
response to mild stress and is referred to as the stress hyporesponsive
period (SHRP) (Levine, 2001). Importantly, intra-amygdala corticos-
terone infusion before training enables precocious odor-aversion
learning and increases amygdala neural activity similar to that seen in
older pups (Moriceau et al., 2006).
As the pup grows older, its locomotion develops and its ecological
niche extends beyond the nest with potential exposure to danger, such
as encounters with predators. Concomitantly, the behavioral response
to odor-shock conditioning shifts from approach/preference to avoid-
ance/fear of the learned odor (Camp and Rudy, 1988; Sullivan et al.,
2000a). This shift coincides with the end of SHRP, with increasing le-
vels of corticosterone in response to stress. Via its action within the
amygdala, corticosterone plays a decisive role in the emergence of
learned odor fear. Indeed, decreasing corticosterone levels in the
amygdala at this age turns the behavior back to preference learning
(Moriceau et al., 2006). Therefore, from postnatal day 10, the amygdala
gets involved in the learning, as well as the posterior piriform cortex
while the anterior piriform cortex is no longer recruited (Moriceau and
Sullivan, 2004; Moriceau et al., 2006; Raineki et al., 2009). This tran-
sition toward a more adult-like behavioral response and underlying
network continues with the pup maturation (Fig. 4).
In adult animals, the role of the amygdala in odor fear learning has
been confirmed in several studies for the different phases of memory
formation: acquisition, consolidation and recall (Cousens and Otto,
1998; Hegoburu et al., 2014, 2009; Kilpatrick and Cahill, 2003b;
Rosenkranz and Grace, 2002; Sevelinges et al., 2004, 2007, 2008).
Besides the central role of the amygdala, many other structures parti-
cipate in the network underlying odor fear learning, going from per-
ipheral sites to highly integrative areas as summarized in Table 2.
Among these different areas, the olfactory piriform cortex plays a
privileged role at different steps of the learning. For instance, it is in-
volved during the very first trials of the acquisition session through
increases in glutamate release (Hegoburu et al., 2014), as well as during
memory consolidation as replay of activity patterns imposed in the
olfactory cortex during post-training slow wave sleep were shown to
enhance the subsequent strength of memory (Barnes and Wilson, 2014)
In addition, Sacco and Sacchetti (2010) reported that excitotoxic lesions
of olfactory secondary sensory cortex impaired remote, but not recent,
odor fear memories in rats. This result has been confirmed using tran-
sient blockade of NMDA receptors in the piriform cortex prior to the
training session (Hegoburu et al., 2014). Together these data suggest
that the piriform cortex is an ideal locus to combine the sensory char-
acteristics of the stimulus with its affective learned value transmitted by
projections from the amygdala, and initiate the long-term storage of the
various attributes of the learned odor. Thus, due to its distinctive
anatomy, the olfactory system constitutes a particularly relevant model
for studying the relative contribution of sensory cortices and amygdalar
nuclei to memory processes.
3.4.3. Long-lasting effects of odor-fear conditioning
3.4.3.1. Effects of neonatal experience on adult emotional and cognitive
abilities. It is well known in the literature of development that early life
maltreatment has deleterious effects on later life cognitive and
emotional processing. Therefore, although the pairing of an odor with
a shock before the age of 10 days induces a learned odor preference in
rat pups, this adverse treatment also has long-lasting adverse
consequences for the individual. Repeated odor-shock pairings have
been shown to model maternal maltreatment (Raineki et al., 2010) and
to induce social behavior deficits in juvenile rats, both toward the
mother (Rincon-Cortes et al., 2015) and toward peers (Raineki et al.,
2012). These deficits persist at adolescence, at which age they are
associated with depressive-like behaviors that are maintained until
adulthood (Raineki et al., 2012; Rincon-Cortes et al., 2015; Sevelinges
et al., 2011). These alterations seem to be mediated in part by a
dysregulation of the amygdala (Raineki et al., 2012; Rincon-Cortes
et al., 2015; Sevelinges et al., 2011, 2007, 2008). Importantly, the
learned attraction displayed by pups toward the odor associated with
shock persists into adulthood, which confers to this odor the ability to
rescue the trauma-induced depression-like behaviors observed in
adolescent and adult rats (Raineki et al., 2012; Rincon-Cortes et al.,
2015; Sevelinges et al., 2011). In addition, it reduces fear-associated
neural activity (Sevelinges et al., 2007), suggesting that it has endorsed
the properties of a safety signal (Pollak et al., 2008).
3.4.3.2. Effects of parental experience on subsequent generations. Odor-
fear conditioning in adulthood leads to the learning of the odor as a
threat signal. This learned fear is long lasting and recent data have
shown that it can be transmitted across generations. Indeed, exposing a
mother to a learned fearful odor in presence of her pups is sufficient to
induce a learned fear to that odor in pups, even before they develop the
ability to learn fear through odor-shock pairing (Debiec and Sullivan,
2014). This learning is maintained at least into adolescence, suggesting
that maternal fear conditioning can have long-term consequences on
the offspring. The highly specific experience of fear conditioning can
also be transmitted to the offspring through non-social mechanisms, via
epigenetic inheritance. Indeed, the offspring of both first and second
generations of male mice conditioned to fear a specific odor shows
increased sensitivity to that odor (Dias and Ressler, 2014). This suggests
that odor fear conditioning in parents can be transmitted to the first
generation through social fear learning but also to the next generations
that have never been exposed to the odor, via epigenetic changes.
Intergenerational transmission of fear is also observed in humans where
it can play an important role in the transmission of maladaptive fears
and anxiety (Bowers and Yehuda, 2016). This passage of fear from one
generation to the next has been observed in offspring of Holocaust and
9/11 survivors, with progeny showing higher risk to develop PTSD and
generally express higher anxiety and lower self-esteem (Bowers and
Yehuda, 2016; Gangi et al., 2009).
Table 2
Structures involved in odor fear conditioning in rodents.
Structure References
Olfactory sensory neurons Dias and Ressler (2014); Kass et al. (2013)
Olfactory bulb Dias and Ressler (2014); Fletcher (2012); Kass and McGann (2017)
Olfactory cortex Hegoburu et al. (2009, 2014); Sacco and Sacchetti (2010); Sevelinges et al. (2004, 2008, 2011)
Amygdala Cousens and Otto (1998); Hegoburu et al. (2009, 2014); Kilpatrick and Cahill (2003b); Sevelinges et al. (2004, 2007, 2008)
Dorsomedial striatum Boulanger Bertolus et al. (2014)
Perirhinal cortex, hippocampus Herzog and Otto (1997); Otto and Poon (2006)
Prefrontal cortex Laviolette et al. (2005); Awad et al. (2015)
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3.4.4. Possible avenues for translational studies
Several studies have investigated the networks involved in fear
conditioning in human using functional brain imaging. Most of these
studies show that the amygdala is part of the circuit, thus corroborating
the data from the animal literature (for a review see Phelps and LeDoux,
2005). Only a few studies have used odor fear conditioning in the lit-
erature. Among them, Li et al. (2008) reported that aversive olfactory
learning enhances perceptual acuity of the sensory signal. Indeed, in-
itially indistinguishable odor enantiomers become discriminable after
aversive conditioning. In parallel, functional brain imaging revealed
that the amygdala response to the conditioned odor increases sharply in
early trials. Interestingly, the authors also measured changes in activity
in the piriform cortex. They reported that spatial patterns of activity in
posterior piriform cortex were highly correlated between the two en-
antiomers before conditioning, but became distinct after conditioning.
Taken together these data indicate that aversive learning induces
plasticity in posterior piriform cortex that correlates with increased
odor enantiomer discrimination. The data obtained in human odor fear
conditioning are strikingly similar to those described in rats and suggest
that while the amygdala plays a crucial role, a broad network of
structures is involved in the learning among which the piriform cortex
seems to endorse a privileged status.
Although odors often trigger involuntary recall of pleasant auto-
biographic memories (Chu and Downes, 2002), they are also particu-
larly powerful to be precipitants of anxiety and fear-related memories
in patients with PTSD (Daniels and Vermetten, 2016). A better under-
standing of the formation and storage of odor fear memories
throughout life might help developing new therapeutic tools to alle-
viate some of the symptoms of anxiety disorders such as PTSD. For
instance, some odors are known to have calming and anxiolytic effects
in both animals (de Sousa et al., 2015) and humans (Dong and Jacob,
2016). Additionally, delivery of odor contextual cues during sleep has
been shown to modulate the strength of associative memories, i.e. en-
hance declarative memory and extinguish fear memory (Hauner et al.,
2013; Oudiette and Paller, 2013; Shanahan and Gottfried, 2014). Ex-
posure of PTSD patients to trauma-related odors during sleep might
help reduce their level of anxiety and alleviate their daily life burden.
3.4.5. Conclusion on olfactory-related fear memory
The olfactory system is an evolutionarily old sensory system with a
well-preserved neural circuitry, at least compared to other sensory
systems, with direct access to brain structures involved in emotion and
memory. Moreover, olfaction is functional at birth, thus suggesting that
the sense of smell has a critical role in controlling behavior throughout
life in mammals. The remarkable flexibility of the olfactory system to
adapt to divergent learning demands as the animal grows and ventures
outside the nest highlights the critical role of olfaction in the formation
of emotional memories.
3.5. Role of genetic and environmental factors in fear memory in animal
models; translational studies of genetic risk factors of PTSD severity in
humans
Fear learning and memory in animal models is often studied using
fear conditioning, passive or active avoidance, or fear-potentiated
startle paradigms. In contextual and cued fear learning and memory, an
environment (context) or cue (such as a tone) are combined with an
aversive stimulus (such as a footshock) and fear learning, memory, and
memory extinction can be assessed (Fanselow and Kim, 1994; Gerlai,
1998; Maren, 2001). Translational fear conditioning tests in humans are
being used based on these animal tests (Milad et al., 2011). The passive
avoidance test involves a two-compartment chamber with a connecting
door; one chamber is lit, which is aversive to small animals, while the
other remains dark (Beatty et al., 1973). The animal receives a slight
footshock when it enters the preferred dark compartment and latency to
re-enter in subsequent training or recall trials is assessed as a measure
of fear memory. In fear potentiated startle, the animal's response to an
acoustic stimulus is potentiated by including a footshock (Missig et al.,
2010).
Importantly, the extinction of fear memory is often studied in the
context of PTSD and forms the basis of exposure therapy. As noted,
PTSD is one of the most common and debilitating anxiety disorders
(Kessler et al., 1995, 2005b). The detrimental effects of PTSD are often
magnified by accelerated development of stress-related medical con-
ditions (Johnson et al., 2015). It is frequently comorbid with other
mental disorders (Horesh et al., 2017), especially anxiety and depres-
sive disorders and has been identified as a major unique identifier for
suicidality (Krysinska and Lester, 2010). PTSD is characterized by the
presence of four distinct symptom clusters: intrusion, avoidance, ne-
gative alterations in cognitions and mood, and alterations in arousal
and reactivity (Pai et al., 2017). Following a traumatic event, many
people experience traumatic stress symptoms, but rates appear to di-
minish quickly over the course of a few months. Thus, PTSD is a con-
dition in which a positive course of recovery from trauma is impeded
(Korol et al., 1999). It has been estimated that close to 90% of people
are exposed to at least one traumatic event, such as rape, assault, dis-
aster, rescue work, or combat, over the course of their lifetime, sug-
gesting that there is something unique about those that continue on to
develop PTSD.
As discussed previously fear conditioning is often used to study the
inhibition or extinction of learned fear, a process believed to underlie
the recurring and re-experiencing symptoms of PTSD (Kong et al.,
2014). The phenomenon of recurring and persistent recall of traumatic
memories in PTSD and related symptoms may be related to a failure of
extinction learning (Charney et al., 1993; Charney and Nestler, 2005)
or a failure to modify or acquire new associations to contextual stimuli
(Lang et al., 2009). Based on these possibilities, conditioned fear has
been widely used to study aspects of PTSD in humans and animal
models (VanElzakker et al., 2014).
The prevalence of PTSD suggests the involvement of environmental
risk factors, including socioeconomic status and education, and asso-
ciations between intensity and number of traumatic events (Breslau
et al., 1998, 1995; Kessler et al., 1995; Sledjeski et al., 2008; Xue et al.,
2015). In animals, an example of an environmental risk factor is X-ray
radiation: after mice were trained in a fear conditioning paradigm, they
were exposed to X-rays and subsequently assessed for fear memory and
extinction of fear memory. Post-training radiation exposure impaired
extinction of both contextual and cued fear memory (Kugelman et al.,
2016; Olsen et al., 2014).
In addition, there is support for a role for genetic risk factors of
either developing PTSD or for severity of PTSD symptoms (Cornelis
et al., 2010; Yehuda et al., 2011; Pitman et al., 2012). For example,
twin studies have provided support for heritable and genetic risk factors
increasing PTSD susceptibility (Kremen et al., 2012). Of the genes that
have been linked to PTSD, the various isoforms of apolipoprotein E
(apoE) are particularly intriguing (Kim et al., 2013; Freeman et al.,
2005). ApoE is an essential component of lipoprotein particles in both
the brain and periphery, and exists in three isoforms in the human
population: apoE2 (E2), apoE3 (E3), and apoE4 (E4) (Mahley et al.,
2000). ApoE plays numerous roles in behavioral and cognitive func-
tions, including regulation of anxiety and cognitive performance during
normal aging and in the context of neurodegenerative disease
(Verghese et al., 2011; Raber et al., 2004; Raber, 2007). Several neu-
robiological functions associated with PTSD have been shown to be
modulated by apoE isoform, including hippocampal volume (Hostage
et al., 2013), cognitive impairment (Caselli et al., 2007), and neu-
roendocrine alterations related to the hypothalamic-pituitary-adrenal
(HPA) axis (Gil-Bea et al., 2010; Peskind et al., 2001; Raber et al.,
2000). Compared to E3, E4 has been associated with decreased brain
metabolism (Reiman et al., 2004), deficient repair following injury
(Laskowitz et al., 1998), and earlier onset and increased risk of Alz-
heimer's disease (AD); conversely, E2 is generally protective against
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cognitive decline (Farrer et al., 1997; Olsen et al., 2012). However, E2
was associated with an increase in the risk and severity of PTSD (Kim
et al., 2013; Freeman et al., 2005). In the first study, E2 was associated
with an increased risk of PTSD and modulated the interaction between
PTSD and alcohol use (Kim et al., 2013). In the second, E2 was asso-
ciated with decreased memory function and more severe re-experien-
cing symptoms in chronic, combat-related PTSD subjects (Freeman
et al., 2005).
Consistent with these two studies, it was recently demonstrated that
homozygous mice expressing human E2 exhibit impaired extinction of
contextual fear memory (Olsen et al., 2012). Several PTSD-like beha-
vioral, cognitive and neuroendocrine alterations are more pronounced
in mice expressing E2. These alterations include a resistance to ex-
posure therapy (fear extinction), alterations in anxiety-like and home
cage behavior, circadian disturbances, and hippocampus-dependent
cognitive impairment following a stressful event. Importantly, data
collected on the severity of PTSD symptoms in combat veterans were
consistent with the mouse data. In a group of 92 veterans with combat-
related PTSD, those with E2/E3 showed significantly higher Clinician
Administered PTSD Scale (CAPS) and PTSD checklist (PCL) scores
compared to E3/E3 and E3/E4 individuals. Alterations in salivary
cortisol within this same group of E2/E3 veterans with PTSD were also
identified. Together, these results support an important role for E2 in
the pathogenesis of PTSD. While it is clear that genetic risks to develop
PTSD exist, recent work demonstrates the importance of considering
epigenetic mechanisms in susceptibility (Heinzelmann and Gill, 2013;
Kwapis and Wood, 2014).
For a complete understanding of acquisition, formation, extinction
of fear memory and individual risk to develop fear-related memory
disorders, baseline genetic and epigenetic differences as well as gene-
environment interactions need to be considered (Fig. 5). Personal
writings prior to being exposed to a traumatic experience might help in
identifying individuals at particular risk to develop a fear memory
disorder. For example, astronauts write in personal journals during
space missions. This important and rich information is being used to
assess a wide range of emotional and psychological states and create a
rank-ordering of behavioral observations (Stuster, 2016). Space mis-
sions, especially extended missions, provide a lot of insights into mental
health and progression of mental health. Previous analysis of hand-
written journals has successfully predicted future cognitive and
Fig. 5. Role of genetic and epigenetic factors as well as gene–environment interactions in acquisition, formation, and extinction of fear memory and individual risk to
develop fear-related memory disorders in mice (A) and humans (B). The smaller font of fear behavior over time indicates extinction of the fear memory. The font of
fear memory not changing indicates impaired extinction of fear memory.
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emotional state. Handwriting complexity of nuns in their twenties was
used to predict risk to develop dementia six decades later (Riley et al.,
2005). More related to fear, handwritten autobiographies from nuns in
their early twenties, were successfully analyzed for emotional content
and related to survival during ages 75 to 95 (Danner et al., 2001). A
strong inverse association was found between positive emotional con-
tent in the writings and risk of mortality in late life. Although important
and very valuable, the journal entries and handwritings are subjective
data. Therefore, it is important to combine these kinds of analyses with
quantifiable objective outcome measures, as typically obtained in
analysis of fear in humans and animal models. These subjective re-
sources, in conjunction with objective measures, can be used in our
multidisciplinary, collaborative effort in affective neuroscience to map
the entire range of human feelings and emotions, allowing us to develop
predictive analyses.
4. Development of treatments for fear learning and memory
disorders
4.1. Fear learning paradigms and contributions to treatment of fear and
anxiety disorders
4.1.1. Observing and quantifying human fear expression: common themes
from “bench to bedside”
The development and symptomatology of stress-, trauma-, and an-
xiety-related disorders such as PTSD are frequently studied through the
use of patient self-report measures. However, the reliability of these
subjective indices can easily be compromised due to the high overlap
between PTSD signs and symptoms and other mental disorders with
which it may be co-morbid (e.g., major depressive disorder, panic dis-
order, generalized anxiety disorder). This overlap makes it difficult for
practitioners and clinical scientists to identify symptoms specific to the
etiology and presentation of post-traumatic sequelae; relevant examples
include shared symptoms of negative cognitions and mood that can
complicate the assessment of PTSD, depression, and/or substance use
and withdrawal (Brown, 1998). Fortunately, well-established, transla-
tional methodologies have emerged that allow clinical researchers to
examine specific subclasses of symptoms in human fear and anxiety
disorders. As discussed earlier, the most notable examples are fear
learning paradigms that provide robust operationalization of the ac-
quisition, extinction, and return of learned fears. Recent work em-
ploying fear learning paradigms has targeted the identification of
trauma- and stressor-related deficits in fear learning as well as putative
neurobiological risk factors for PTSD and related mental disorders
(Briscione et al., 2014).
PTSD is a complex, heterogeneous disorder that spans several do-
mains of a patient's daily experience including quality of life, emotional
regulation, anger and irritability, and social functioning, however,
central features of PTSD are mediated by impairments in learned fear
metabolism (Norrholm and Jovanovic, 2010; Zuj et al., 2016). The
experience of a traumatic event can be conceptualized as a brief,
compressed, and durable form of fear acquisition, according to Pavlo-
vian principles (Rothbaum and Davis, 2003). Exposure to a threat to
one's integrity or survival (e.g., combat trauma) serves as an uncondi-
tioned stimulus (US) that can evoke a psychobiological fear response in
the absence of any previous learning. Environmental stimuli (e.g.,
sights, sounds, smells of the Middle Eastern landscape for combat ve-
terans and civilians) can acquire fear-eliciting properties based on their
association with the unconditioned, unexpected, traumatic event. As a
result, an individual who was present at the time of the pairing between
the trauma and ambient surrounding stimuli may acquire a persistent
fear to these cues (that can be termed conditioned stimuli (CS) ex-
perimentally or “triggers” clinically). Laboratory fear learning methods
often include psychophysiological indices such as fear-potentiated
startle, skin conductance, or heart rate variability, allowing in-
vestigators to observe and quantify this type of learning in traumatized
human populations (Michopoulos et al., 2015).
In a typical translational fear conditioning paradigm, fear acquisi-
tion occurs when a previously neutral stimulus or CS, is repeatedly
paired with an aversive outcome or US (e.g., an aversive airblast to the
larynx for humans (Norrholm et al., 2006) or cutaneous electric shock
(Schiller et al., 2012). Similar to animal models, a widely used psy-
chophysiological tool for studying human fear learning is fear-po-
tentiated startle, in which the relative increase in the frequency or
magnitude of the acoustic startle reflex is assessed before, during, and
after an association is developed between a CS and US. This paradigm's
clinical utility has substantiated from fear-potentiated startle methods
that have been employed to characterize physiological responses ac-
companying exaggerated fear expression, contributing considerable
data to clinical applications and treatment of PTSD and fear-related
disorders (Norrholm et al., 2015).
Fear memories are not permanent and can be strengthened or
weakened through laboratory and clinical methods that can alter the
expression of conditioned fear (Myers and Davis, 2002). As expected,
extinction learning is evident in fear-potentiated startle paradigms as a
within- and between-session decrease in the intensity of the acoustic
startle response during and following repeated, non-reinforced CS
presentations (Norrholm et al., 2011a, 2006, 2008).
Fear extinction recruits a form of new learning in which an in-
hibitory memory trace associated with the previously reinforced CS
competes with, but does not eliminate, the labile fear acquisition
memory trace (Liberzon and Abelson, 2016; Myers and Davis, 2002). As
described earlier, the original fear memory remains intact and is ac-
cessible through specific learning mechanisms identified as reinstate-
ment (through unsignaled presentation of the previously used US;
Bouton and Bolles, 1979; Rescorla and Heth, 1975), renewal (through a
change in experimental context; Bouton, 1993), or through the passage
of time (termed spontaneous recovery; Pavlov, 1927). Clinically
speaking, the learning and memory principles of reinstatement, re-
newal, and spontaneous recovery are observed in symptom relapse
following a change in environment (e.g., from therapist's office to
home), time elapsed since cessation of extinction-based treatment (e.g.,
prolonged exposure therapy), or experiencing a stressful life event (e.g.,
health crisis or subsequent trauma re-exposure), respectively (Briscione
et al., 2014). It is important to note here that the return of an original
fear memory following extinction learning can be readily observed in
the laboratory (for examples see Norrholm et al., 2014, 2011b; Warren
et al., 2014).
Fear extinction learning in humans represents a viable avenue for
studying the acquisition, extinction, and return of conditioned fear. An
emerging area of interest as it relates to impaired fear learning as a
central feature of PTSD is the heterogeneity that exists in the expression
and extinction of learned fears. Traditional studies of psychiatric po-
pulations recruit a group of interest (e.g., traumatized veterans or ci-
vilians) and compare their results with that of an appropriate control
sample at the group level or through a between-groups comparison of
averaged data. Consistent with initiatives toward individualized medi-
cine, there are efforts underway to further explore individual differ-
ences and potential subclasses of responders in clinical science. For
example, the employment of statistical techniques such as latent growth
mixture modeling (LGMM) allows investigators to determine under-
lying subclasses based on a specific variable of interest. This approach
has recently been employed in the study of fear-related behaviors at the
clinical level as well as conditioned fear responses derived from the
laboratory (Galatzer-Levy, 2015; Galatzer-Levy et al., 2017, 2013). For
example, individuals who have been traumatized and/or diagnosed
with PTSD have predictably shown delayed, slower, or even non-
existent rates of fear extinction when compared to non-traumatized
populations (Galatzer-Levy et al., 2013).
The study of human fear acquisition and extinction remains clini-
cally relevant for a number of reasons based on an extensive body of
literature spanning the past five decades. As previously discussed, one
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of the most effective psychotherapeutic interventions for PTSD and
other trauma- and stressor-related disorders is PE (Foa and McLean,
2016). This strategy seeks to help individuals establish a dominant
extinction memory trace, in which trauma-related cues signal safety
rather than harm through graduated exposure to fear-provoking CS or
triggers. The learning mechanisms underlying PE can be recruited
through laboratory extinction learning and, as such, allow researchers
to identify intermediate phenotypes underlying fear-related psycho-
pathologies (Norrholm et al., 2014). One such phenotype is termed fear
load, or the amount of conditioned fear exhibited during early extinc-
tion, which has shown to be prognostic of intrusive symptoms
(Norrholm et al., 2014). Additionally, supplementary factors can be
considered when clinicians administer exposure-based treatments, as
research suggests that factors such as time of day, cognitive resources,
and menstrual phase can influence fear extinction profiles (Glover
et al., 2012, 2015; Milad et al., 2006a).
In addition to research aimed at improving clinical population
treatment outcomes, it may also be worth investigating the potential
cost of repeated trauma exposure in non-clinical populations (Levy-Gigi
and Richter-Levin, 2014). Identifying individuals who are at risk for
fear learning deficits following trauma exposure, regardless of clinical
status, could be helpful for preventing said deficits. For example, in-
troducing contextual-cue processing skills before trauma exposure
could reduce the advancement of fear learning deficits in individuals
with high-risk occupations.
In summary, it is increasingly vital to consider the literature that
supports psychophysiological measures as valid tools to predict clinical
risk factors and treatment outcomes for PTSD and trauma and stress-
related disorders. Although PTSD is not defined as a fear-centric or fear-
conditioning disorder, fear learning mechanisms are a fundamental
component of this and related disorders. Notably, assessments of fear
learning and extinction have introduced new discoveries about the
behavioral, cognitive, and neurobiological underpinnings of trauma's
psychophysiological effects. Evaluating fear extinction learning, varia-
bility, and retention may serve a critical role in the future of improving
individualized treatment efficacy for trauma-related disorders and
predicting clinical pathology or resilience.
4.2. Mechanisms of action of existing treatments for PTSD and development
of novel therapeutic strategies for PTSD
4.2.1. Current treatments for PTSD
Pharmacological treatments for PTSD, including antidepressants
and antihypertensives, were originally developed for other disorders
and only later tested clinically for PTSD (reviewed in Bernardy and
Friedman, 2017). While they provide a certain degree of improvement
of PTSD symptoms, these treatments fail to cure the specific neuro-
biological deficits characteristic of PTSD. In the 1980s, clinical trials
supported the use of tricyclics (TCAs) and monoamine oxidase inhibitor
(MAOI) antidepressants (Davidson, 2015) but with the advent of the
selective serotonin re-uptake inhibitors (SSRIs), the latter medications
became more commonly used as first-line PTSD treatments. Since then,
paroxetine and sertraline are the only FDA approved medications for
PTSD (reviewed in Bernardy and Friedman, 2017; Locci and Pinna,
2017). Subsequent clinical trials assessed the SNRI venlafaxine to be
beneficial in treating PTSD symptoms (Watts et al., 2013), with one
trial in particular finding venlafaxine highly effective compared to
SSRIs (Lee et al., 2016). Nefazodone is another treatment option;
however, side effects are more prominent and include the risk of liver
failure (Baldwin et al., 2014; Hoskins et al., 2015; Lee et al., 2016).
It is not uncommon, unfortunately, for pharmacological treatment
to fail at improving patients’ symptoms. First line trauma-focused
psychotherapy, including PE, is helpful when a pharmacological treat-
ment fails, and is considered the rule rather than the exception. Indeed,
only about half of patients respond to SSRIs and more than a third of
SSRI-treated patients fail to respond, do not reach full remission, or
even develop SSRI resistance (Bernardy and Friedman, 2015; Golden
et al., 2002; Kemp et al., 2008; Rush et al., 2006). Furthermore, most
patients who initially respond to SSRI treatment fail to maintain ther-
apeutic gains over time. In particular, veterans affected by PTSD are
generally resistant to SSRI therapy (Friedman et al., 2007; Prigerson
et al., 2001; Schnurr et al., 2007). Similarly, general abuse – but
especially abuse and neglect at a young age – predicts a lower response
to SSRIs (Williams et al., 2016). Treatment becomes even harder when
chronic PTSD patients present with comorbid mood disorders, such as
major depressive disorder and drug abuse; ultimately, these people are
less likely to be successfully treated (Friedman et al., 2007; Kessler
et al., 2017).
For those who fail to achieve complete remission from PTSD fol-
lowing pharmacotherapy, PE in combination with an SSRI can be the
best option rather than receiving adjunctive medication. PTSD patients
related to World Trade Center attack who received paroxetine in
combination with PE showed greater improvement compared to in-
dividuals who received PE alone (Schneier et al., 2012). Among adjunct
pharmacological treatments adopted to enhance cognitive-behavioral
therapy, DCS and hydrocortisone are some of the most common to be
used for PTSD. Several studies have failed to find improvement with
DCS, however, while hydrocortisone, which was evaluated to enhance
PE, was found to be beneficial in veterans with PTSD (de Kleine et al.,
2012; Hofmann et al., 2015; Litz et al., 2012; Rothbaum et al., 2014).
As sleep disturbances are common in PTSD patients and can worsen
perceived levels of stress, depression, and suicidal thoughts, they are
often a focus of treatment. Trazodone and prazosin are widely used
treatments for PTSD. The alpha-1 adrenergic receptor antagonist pra-
zosin and the alpha-1 adrenergic receptor antagonist and 5-HT2 re-
ceptor antagonist trazodone are being used to treat sleep disturbances
in PTSD (Thomas, 2014). However, the beneficial effects of prazosin on
sleep disturbances are not clear (McCall et al., 2018).
Collectively, current pharmacotherapy for PTSD relies mostly on
fluoxetine, paroxetine, sertraline and venlafaxine alone or in combi-
nation with PE. The beneficial therapeutic gains are modest with all of
these, (Bernardy and Friedman, 2015; Locci and Pinna, 2017), hence,
the development of new agents that act through different mechanisms
(rather than inhibition of serotonin reuptake) or new therapeutic stra-
tegies that can help treatment-resistant patients, is needed. This also
suggests the need to develop biomarker-based therapy designed for
specific trauma-exposed individuals who develop PTSD and fail to re-
spond to traditional treatments (Pinna and Izumi, 2018). Undisputable
progress has been made to assess the validity of biomarkers for psy-
chiatric disorders, although, the field still remains underdeveloped
compared to other fields of neuroscience (Fernandes et al., 2017). In-
vestigation toward discovering potential novel biomarkers to guide
precision medicine for the treatment of PTSD, and thereby, prompting
the development of novel and specific treatments and increasing the
success of clinical trials, is thus required.
Recent advances in the field suggest biomarker-based treatments for
PTSD may not be a far reach (discussed in Aspesi and Pinna, 2018).
Employing more sophisticated methodological tools and the search for
valid animal models, has also become essential to reliably correlate
behavioral changes of the disorder with neurochemical alterations
(reviewed in Ngounou Wetie et al., 2013). The overlap of symptoms
and the comorbidity with other psychiatric disorders, and even with
suicidal ideation and drug abuse disorder, suggest a biosignature for
PTSD should include a set of biomarkers rather than just a few (Locci
and Pinna, 2017). A refined approach to more specifically and un-
ambiguously “biodefine” PTSD might be one of establishing a biomarker
axis; or in other words, assessing the interrelation of various bio-
markers, which fluctuate in concert and correlate with behavioral
modifications, will reveal a more nuanced description. Insofar, a bio-
marker axis may provide a higher accuracy in the diagnosis of the dis-
order with benefits for prediction in PTSD treatment response and re-
lapse (discussed in Locci et al., 2018; Pinna and Izumi, 2018). Progress
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in assessing predictors of PTSD development and treatment response
and biomarkers for the unique neurobiology of PTSD will guide the
future of novel PTSD medications designed to act on a range of GA-
BAergic, glutamatergic, adrenergic, neuroendocrinologic, as well as
inflammatory targets.
4.2.2. Unveiling new biomarkers and treatment options for PTSD
SSRIs are the most widely used agents to treat PTSD. They act
through a number of recently characterized molecular mechanisms
rather than just by inhibiting serotonin reuptake (Pinna, 2015). Ex-
amples of other mechanisms include the stimulation of the proges-
terone metabolite, allopregnanolone biosynthesis and of neurotrophic
factors, such as BDNF. Both allopregnanolone concentrations and BDNF
expression are found deficient in PTSD (reviewed in Nin et al., 2011).
These findings not only have contributed to our understanding of PTSD
neurobiology but they also stimulated the development of novel, tar-
geted treatment options and improved therapeutic strategies. In this
respect, impairment of neuroactive steroid concentrations and beha-
vioral abnormalities in neuropsychiatric disorders, including PTSD and
major depression has been extensively studied.
As outlined below, the positive GABAergic modulator allopregna-
nolone and its equipotent isomer, pregnanolone, have been of special
interest. In rodent models, a reduction of corticolimbic allopregnano-
lone levels by prolonged social isolation or exposure to single prolonged
stress, two putative rodent models of PTSD (Aspesi and Pinna, 2019),
resulted in development of anxiety-like behavior, aggression and
Fig. 6. Novel treatment strategies to regulate emotional behavior. Allopregnanolone (Allo) and its equipotent stereoisomer pregnanolone (PA) are synthesized in
glutamatergic corticolimbic pyramidal neurons and after their secretion, they act as positive allosteric modulators of the action of GABA at GABAA receptors located
on cell bodies or dendrites of pyramidal neurons (Agis-Balboa et al., 2007, 2006; Pinna et al., 2000). Allopregnanolone’s neurophysiological role in regulating the
fine-tuning of GABAA receptors is involved in the regulation of emotional behavior (Pinna and Izumi, 2018; Pinna et al., 2000). Sulphotransferase converts allo-
pregnanolone and pregnanolone into allopregnanolone sulfate (Allo-S) and pregnanolone sulfate (PAS). Pregnanolone sulfate inhibits NMDA receptors, which has
relevance for neuroprotection (Vyklicky et al., 2016) and may play a role in the regulation of cognition and emotional behavior (reviewed in Locci and Pinna, 2017).
Depicted are several strategies to improve PTSD symptoms by increasing corticolimbic allopregnanolone levels or by directly activating GABAA receptors. 1. The
intracellular peroxisome proliferator-activated receptor (PPAR-α), a cannabinoid target heterodimerize with the retinoid X receptor (RXR) and initiates transcription.
Given that endocannabinoids activate PPAR-α, the activation of these nuclear receptors represents a novel mechanism by which cannabinoids and ethanolamides
may modulate behavior. The ethanolamide, N-palmitoylethanolamine (PEA) is a PPAR-α endogenous agonist, which is decreased in PTSD patients (Wilker et al.,
2016). Recent preclinical findings showed that supplementing PEA in rodent PTSD models improves emotional behavior by enhancing allopregnanolone biosynthesis
in corticolimbic glutamatergic neurons (Pinna and Izumi, 2018). 2. Agonist for the CB1 receptor may also improve behavior by activating pregnanolone biosynthesis
(Vallée, 2016; Vallée et al., 2014). 3. TSPO ligands may induce an upstream stimulation of neurosteroidogenesis by enhancing the entry of cholesterol into the inner
mitochondrial membranes of glial cells, and stimulating its conversion into pregnanolone. Pregnanolone is then taken up by glutamatergic neurons and increase
downstream allopregnanolone levels. 4. Pregnanolone can also be sulfated to pregnanolone sulfate and act at NMDA receptor. 5. Low doses of SSRIs induces a
downstream activation of allopregnanolone concentrations by acting at 3α-HSD. 6. Administration of allopregnanolone or allopregnanolone's analogs (e.g., ganax-
olone) by directly activating GABAA receptors may also improve PTSD and other psychiatric disorders characterized by impaired neurosteroidogenesis. Modified
from Pinna (2018).
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enhanced contextual fear conditioning responses (Dong et al., 2001;
Pibiri et al., 2008; Pinna and Rasmusson, 2014; Zhang et al., 2014b).
Similar associations have been found in humans: a reduction in the
concentration of allopregnanolone and pregnanolone was observed in
cerebrospinal fluid (CSF) and serum of unipolar depression and PTSD
patients (Pineles et al., 2018; Rasmusson et al., 2006; Schüle, 2014;
Uzunova et al., 1998). In particular, Rasmusson and colleagues showed
that a marked decrease in the CSF and blood levels of allopregnanolone
and pregnanolone in women negatively correlated with PTSD re-ex-
periencing and comorbid depression (Pineles et al., 2018; Rasmusson
et al., 2006). A negative correlation between CSF allopregnanolone
concentrations and PTSD total CAPS was more recently confirmed in
male patients (Rasmusson et al., 2016). Likewise, patients affected by
depression showed downregulation of allopregnanolone biosynthesis in
serum, plasma, CSF, and prefrontal cortex Brodmann's Area 9 (Agís-
Balboa et al., 2014; Romeo et al., 1998; Uzunova et al., 1998; Van
Broeckhoven and Verkes, 2003) (reviewed in Locci and Pinna, 2017;
Pinna, 2014). In support, a number of clinical investigations underlie
the relevance of allopregnanolone biosynthesis as a biomarker of af-
fective disorders, as reported by observations demonstrating decreased
downregulation of allopregnanolone concentrations in postpartum de-
pression (Nemeroff, 2008); following treatment with finasteride, an
agent that inhibits allopregnanolone biosynthetic enzymes (Altomare
and Capella, 2002; Welk et al., 2017); and in patients with anorexia
nervosa or obesity affected by anxiety spectrum disorders and depres-
sive symptoms (Dichtel et al., 2017). In this respect, it is intriguing that
administering SSRIs upregulates serum, plasma, CSF, and brain allo-
pregnanolone concentrations in association with remission of beha-
vioral symptoms (Agís-Balboa et al., 2014; Romeo et al., 1998; Uzunova
et al., 1998).
The normalization of allopregnanolone concentrations must cer-
tainly be included in the multiple mechanisms of action for the anti-
depressant and anxiolytic effects of SSRIs (Pinna, 2015). Furthermore,
preclinical studies are in support of allopregnanolone biosynthesis and
its interaction with GABAA receptor subtypes as a biomarker candidate
for stress-induced behavioral abnormalities, which include in-
appropriate and exaggerated fear responses and impaired fear extinc-
tion, which are a core feature of PTSD neurobiology (Pibiri et al., 2008;
Pinna and Izumi, 2018; Pinna and Rasmusson, 2014). This evidence
also suggests new treatments that counteract the stress-induced down-
regulation of neurosteroid concentrations may improve symptoms of
PTSD. Several neuronal targets to enhance steroidogenesis have re-
cently been discovered and offer promising therapeutic approaches to
improve emotional symptoms by increasing neurosteroid levels and
modulating neurotransmitter systems (Aspesi and Pinna, 2019) (sum-
marized in Fig. 6). Assessing subpopulations of PTSD patients for
downregulation of allopregnanolone biosynthesis, and subsequently
treating those patients with neurosteroidogenic agents, such as drugs
that act at the translocator protein (TSPO) receptor or the en-
docannabinoid system, or with allopregnanolone mimetics could be a
new form of precision medicine. Intriguingly, recent phase 3 clinical
trials demonstrated a fast remission of post-partum depression in 70%
of patients after a two-day course of intravenous allopregnanolone
(Kanes et al., 2017; Locci and Pinna, 2019). These results have led to
the FDA approval of allopregnanolone for postpartum depression on
March 2019.
The description that follows on neuronal targets that are currently
explored for the development of novel treatments for PTSD, ties back
into allopregnanolone biosynthesis.
4.2.3. Endocannabinoids, CB1 and PPAR-α agonists
The therapeutic relevance of cannabinoids for PTSD has been the
focus of several debates. Cannabis is often used as a self-medication by
patients (Bernardy and Friedman, 2015; Bonn-Miller et al., 2014;
Cougle et al., 2011; Earleywine and Bolles, 2014), which is primarily
composed of THC and cannabidiol (CBD) (Bergamaschi et al., 2011;
Budney et al., 2004). This is likely facilitated by a greater cannabinoid
receptor density in patients with PTSD (Neumeister et al., 2013). Most
studies on the effects of cannabinoids on fear memory have focused on
increasing fear extinction by targeting CB1. Stern et al. (2015) found
CBD administered immediately after memory retrieval disrupted con-
solidated fear memories, and persisted for 22 days after application.
Administration of THC and THC+CBD resulted in a similar effect
(Stern et al., 2015). These data are in support of a role for CBD and THC
on modulation of fear in PTSD by facilitating extinction learning
through a reconsolidation blockade. CBD may also decrease anxiety and
anhedonia and THC may reduce nightmares and insomnia in PTSD
(reviewed in Loflin et al., 2017). Two randomized controlled clinical
trials of THC, CBD, and the combination of THC+CBD to assess effi-
cacy to treat PTSD are ongoing (e.g., NCT02759185 and
NCT02517424).
Recent evidence also suggests that the endocannabinoid and the
neurosteroid systems are inter-related. Evidence shows both allo-
pregnanolone and the endocannabinoid, anandamide (AEA) levels are
low in depression and PTSD and in animal models of anxiety and de-
pression (Hill et al., 2013, 2008; Rasmusson et al., 2006; Romeo et al.,
1998; Uzunova et al., 1998). Moreover, CB1 is highly expressed in
neurons where enzymes for neurosteroidogenesis are also present, and
in brain areas that regulate fear responses, such as hippocampus and
amygdala (Katona, 2009). Of note, THC induces a 30-fold increase of
the allopregnanolone's precursor, pregnanolone by acting on CB1
(Vallée, 2016; Vallée et al., 2014). Thus, the endocannabinoid system
may be a novel pharmacological target to elevate allopregnanolone
biosynthesis and facilitate fear extinction in PTSD patients.
Another endocannabinoid target that has recently been examined
for its ability to induce allopregnanolone biosynthesis is the peroxisome
proliferator-activated receptor (PPAR)-α class of nuclear hormone re-
ceptor, which is involved in several cellular and molecular mechanisms
regulating neuroinflammation (Pinna, 2018). The endocannabinoid,
palmitoylethanolamide (PEA) induce potent antidepressant effects by
acting at PPAR-α (Yu et al., 2011) and recent studies have demon-
strated PEA increases allopregnanolone levels in the spinal cord and
brain stem. More importantly, PEA-induced increase of allopregnano-
lone in the hippocampus and amygdala was associated with faster fear
extinction learning and improvement of aggression in socially-isolated
mice (Locci et al., 2017; Locci and Pinna, 2017; Sasso et al., 2012).
These findings highlight a fine network that coordinates the neuro-
steroid and the endocannabinoid systems. Hence, novel cannabinoid-
like agents with neurosteroidogenic properties but devoid of psycho-
tomimetic effects could be beneficial pharmacological therapies for
PTSD patients.
4.2.4. Translocator protein (TSPO) agonists
TSPO is located on the outer mitochondrial membrane and plays an
important role in cholesterol transport onto the inner mitochondrial
membrane (depicted in Fig. 6). Stimulation of the TSPO receptor results in
a downstream increase of allopregnanolone levels. In mouse models of
PTSD, TSPO ligands (AC-5216/XBD173 and etifoxine) potently increase
allopregnanolone levels in the hippocampus and cortex and improve an-
xiolytic-like behavior (Kita et al., 2004). Intriguingly, these findings have
been demonstrated also in studies conducted in anxious patients
(Rupprecht et al., 2010; Rupprecht et al., 2009; Schüle, 2014). AC-5216/
XBD173 and YL-IPA08 also improve PTSD-like behavior in rodent studies
of situational reminders and contextual fear responses (Qiu et al., 2013).
Chronic administration with YA-IPA08 markedly reduced anxiety-like
behavior and contextual fear responses in mice exposed to single-pro-
longed stress, an effect that was inhibited by the TSPO antagonist,
PK11195 (Zhang et al., 2016, 2014b). Behavioral improvements induced
by YA-IPA08 were positively correlated with increased serum and cortical
allopregnanolone levels (Zhang et al., 2014b). The evidence thus far
suggests that TSPO agonists could be future therapeutic agents for PTSD,
and should be further explored for this potential.
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4.2.5. Selective brain steroidogenic stimulants (SBSSs)
A strategy to facilitate fear extinction deficits in PTSD patients
might be offered by administering low doses of SSRI antidepressants
(see Fig. 6). Laboratories have shown that low doses of SSRIs (i.e., 1/10
of the doses that inhibit 5-HT reuptake), which fail to affect ser-
otonergic mechanisms, normalize allopregnanolone levels and improve
PTSD-like behavior in allopregnanolone-deficient mice (Pinna, 2013,
2004) by acting as selective brain steroidogenic stimulants (SBSSs) (Pinna
et al., 2006). SSRIs are associated with high non-response rates in the
treatment of PTSD patients at doses that engage serotonergic mechan-
isms (reviewed in Pinna, 2015). Hence, one may wonder whether a low
dosage of an SSRI may be more effective in PTSD treatment. Clinical
trials should be conducted to establish whether SSRI at low neuro-
steroidogenic doses offer a pharmacological advantage over SSRI doses
that are currently prescribed in the treatment of PTSD and depression.
SBSSs may provide benefits in selected subpopulations as adjunct
treatment in trauma-focused therapy for PTSD (e.g., PE or CTP). Inter-
estingly, findings from Dr. Lovick support the use of low neuroster-
oidogenic doses of fluoxetine to improve premenstrual syndrome, a
disorder characterized by a rapid drop of neuroactive steroid levels
(Lovick, 2013).
4.2.6. Allopregnanolone analogs
Administration of allopregnanolone or its analog, ganaxolone, im-
proves behavioral dysfunction related to corticolimbic allopregnano-
lone deficits (Pinna and Rasmusson, 2014). Ganaxolone, administered
immediately after reactivation, facilitated fear extinction and, more
importantly, enhanced fear extinction retention at recall, suggesting a
long-lasting effect (Pinna and Rasmusson, 2014). Ganaxolone also
showed anxiolytic and antiaggressive effects (Locci et al., 2017). Other
synthetic neurosteroid analogs, BR351 or BR297 reduces aggressive
behavior and their effects on fear extinction are currently being ex-
amined (Locci et al., 2017).
4.2.7. Precursors of allopregnanolone and sulfated congeners
Administration of the allopregnanolone precursor pregnanolone
reduced neuronal activity in brain regions associated with generation of
negative emotions in response to emotional stimuli (Sripada et al.,
2013). Hence, administering directly allopregnanolone or its precursors
may be valuable treatment options to improve efficacy of exposure-
based cognitive treatments for PTSD (Fig. 6).
Sulfated neurosteroids are currently the focus of interesting treat-
ment developments in neuropsychopharmacology. The inhibitory role
of pregnanolone sulfate (PAS) on NMDA receptors has just recently
been discovered (depicted in Fig. 6). PAS is specifically potent at in-
hibiting tonic rather than synaptically activated NMDA receptors
(Vyklicky et al., 2016). Activation of synaptic NMDA receptors is im-
portant for neurophysiological processes, including synaptic plasticity,
learning and memory, and synaptogenesis, while tonic NMDA receptor
activation results in excitotoxicity. This mechanism is relevant for de-
veloping a novel class of steroid-based NMDA-inhibitors as therapeutics
with the benefit of being devoid of ketamine-like psychotomimetic side
effects. Several PAS analogs have recently been developed (Adla et al.,
2016) that show no activity at synaptic NMDA receptors but are highly
selective on tonic-activated receptors (Vyklicky et al., 2016). Collec-
tively, neurosteroids that potentiate GABAergic neurotransmission and
their sulfated derivatives that inhibit tonic NMDA receptor neuro-
transmission may work in concert to improve cognitive and emotional
deficits in PTSD patients.
4.3. The role of subjective experience in fear
Fear is a common human emotion. As is true for all emotions, fear is
a private experience that cannot be observed directly. Scientific studies
of such inner experiences typically require some form of self-reporting.
People can only provide a verbal report of information if it is processed
consciously. We argue here that subjective reports of fear (and other
emotions) are not unreliable proxy measures of emotions, as suggested
by some theorists. Rather, they are the best direct, and, so far, the only
easily accessible measures of emotions. In fact, verbal self-report re-
mains the gold standard in studies of consciousness and emotions, in-
cluding fear.
Because non-verbal reporting is the only option in non-verbal (non-
human) organisms, determining whether other animals have conscious,
subjective experiences is difficult to ascertain. While other methods of
measurements that do not require verbal report may exist, these also
depend on introspection. As we discussed elsewhere (LeDoux and
Hofmann, 2018), we argue here that use of the term “fear” (as well as
other emotion words) should be restricted to subjective experiences in
order to eliminate much of the conceptual confusion when discussing
emotions. We recommend that future research examine the relationship
between subjective report, behaviors, and physiological responses of
fear and anxiety in order to explain the reasons for the dissociation that
has been reported in the literature between these measures.
The theoretical framework to incorporate consciousness and emo-
tions is provided in the high-order theory of emotions (LeDoux and
Brown, 2017), which builds on recent developments in the science and
philosophy of consciousness, arguing that a general network of cogni-
tions underlies both cognitive and emotional states of consciousness.
What distinguishes cognitive and emotional states of consciousness, and
different kinds of emotional states in higher-order emotion theory is the
kind of inputs processed. The subcortical circuit is the defensive sur-
vival circuit that detects and responds to threats. The consequences of
defensive survival circuit activation (such as brain arousal, body feed-
back, etc.) contribute indirectly to the experience of fear but do not
determine it (LeDoux and Pine, 2016).
Fear is then the product of the cognitive assessment that we are in
harm's way, a view that allows fear to arise from activity in any survival
circuits (fear of being harmed by starvation, dehydration, hypothermia,
reproductive isolation, and so forth), or by existential concerns (such as
fear of the eventuality of death or the meaninglessness of your life), in
addition to predatory-related dangers that trigger the defensive survival
circuit (LeDoux, 2015a; LeDoux and Pine, 2016).
We believe that the clinical relevance is evident. The primary reason
why people seek the help of mental health specialists is because they
feel bad and want to feel better. A treatment that reduces behavior
(avoidance) and physiological responses (hyperarousal) but does not
diminish subjectively reported fearful feelings is not likely to be viewed
as a satisfactory outcome by the suffering person.
In the contemporary treatment literature, self-reports, and the
subjective experiences that these reports reflect, have not been given
much credence. This may reflect the influence of behaviorism in the
development of both traditional behavioral therapy and cognitive be-
havioral therapy, as well as findings suggesting that behavioral phy-
siological responses related to fear and other emotions in humans are
poorly correlated (Hodgson and Rachman, 1974; Lang, 1968; Rachman
and Hodgson, 1974).
Today, most therapists routinely use subjective patient report as
part of treatment. Although the reduction in reported fear ratings
during an exposure session is, in fact, an important factor that de-
termines the success of treatment (e.g., Hofmann, 2014), the value of
self-report measures continues to be debated. We conclude that self-
report assessments of fear are crucially important for measuring this
human emotion.
4.4. Role of the cholinergic system in PTSD; potential of miRNA as
therapeutic strategy
Fear is an integral part of human life, ranging from day-to-day an-
xiety experienced by each parent to international terror bursts with
increasing incidence and spread. The strong bodily sensation of fear,
sensed by each of us to varying degrees, raises questions regarding the
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underlying molecular changes induced by such an intense reaction, as
well as the regulators of long-term fear-inducible physical and mental
consequences, and the interactions between them. These questions may
be addressed by combining molecular (Meydan et al., 2016) and neu-
rocognitive (Arzy et al., 2009, 2011; Craig, 2002) approaches and
subjecting the findings to advanced analyses that are aimed at assessing
the impact of these risks on human health and wellbeing (Peer et al.,
2017; Soreq, 2015). For instance, a population-based analysis was used
to investigate the consequences of the repeated exposure of the Israeli
population to chronic terror-related stress. It was found that consistent
exposure to terror threats ignites combined annual increases in pulse
rate and in the inflammatory biomarker C-reactive protein, indicating
acquired neuro-immune risks of all-cause mortality (Shenhar-Tsarfaty
et al., 2014).
The intense physiological reaction induced by fear immediately
impacts bodily and nervous circuits through sympathetic and dopami-
nergic activation. Fear and stress are therefore known to facilitate the
emergence of major neuropsychiatric disorders, such as schizophrenia.
The relationships between environmental, bodily and neurocognitive
mechanisms have been well established (Blanke, 2012; Craig, 2002).
However, how these relationships are translated to the underlying
molecular level remain unclear. Several candidates are gaining trac-
tions, though: for instance, at the genomic level, there is evidence for
the putative involvement of microRNA (miR) regulators (Bartel, 2009)
in both neuronal and immune processes (Soreq and Wolf, 2011). The
small and effective miR molecules may lead to rapid, yet reversible,
changes in stress-inducible pathways (Fig. 7). Application of lentivirus-
mediated suppression of acetylcholinesterase (AChE) clearly revealed
both cognitive and metabolic implications of the stress-induced AChE-
targeting miR-132. Importantly, miR-132 is evolutionarily conserved,
and interactions of miR-132 and AChE are causally involved in mini-
mizing the cognitive damages induced by acute stress events (Shaltiel
et al., 2013). Recent clinical reports of dementia following chronic use
of cholinergic suppressors (such as pharmaceutical blockers of mus-
carinic receptors to control incontinence) provide further support for a
critical role of cholinergic function in fear and age-related neurode-
generative conditions (Weinstein et al., 2018). In peripheral tissues, the
stress-accompanying impact of miR-132 elevation extends to hepatic
Fig. 7. Personalized aspects of cholinergic fear reactions in
mouse and human brain analyses. (A) Imbalanced acetylcho-
line (ACh) levels lead to excessive fear reactions (hyper-acti-
vated cholinergic signaling) or cognitive injury (prolonged
suppression). Acetylcholinesterase (AChE) degrades ACh,
serving as the balancing enzyme (Soreq, 2015). (B) Following
foot-shock stress, mice fail to locate a hidden platform in the
Morris Water Maze test (Shaltiel et al., 2013). Intracerebrally
injection of a viral suppressor of AChE (shAChE) leads to ac-
tivation of cholinergic signaling and improves navigation of
stressed mice to the platform as compared to mice injected
with a control virus (shCON) (Shaltiel et al., 2013). (C) Small
microRNA (miR) regulators of cholinergic gene expression
wrap around their target gene products, block protein ex-
pression and consequently the signaling balance. miRs may
each interact with many targets. Each target may be con-
trolled by many miRs. (D) Humans under long-term fear of
terror show impaired cardiac functioning and several PTSD
symptoms (Shenhar-Tsarfaty et al., 2015). (E) Mice under fear
prefer the enclosed over the more anxiety-provoking open
arms of the elevated maze (top). In humans with PTSD, hyper-
activated amygdala and suppressed pre-frontal cortex (PFC)
functioning is observed in functional MRI (fMRI) (bottom). (F)
Human carriers of a single nucleotide polymorphism (SNP) in
the AChE gene's miR-608 binding site show a hyper-activated
PFC, an interrupted amygdala response, and no post-stress
symptoms (Lin et al., 2016), whereas humans with a SNP in
the primate-specific miR-608 gene show reduced risk of sepsis
following head injury (Zhang et al., 2015). Cholinergic genes
(e.g., butyrylcholinesterase, BChE; vesicular ACh transferase,
VAChT) and/or their miR targets may modify fear and in-
flammatory responses. Suppression by miR-608 of its other
targets, including CDC42 and IL6 is modified in SNP carriers
(Hanin et al., 2014). SNPs in the AChE binding sites of other
miRs (Simchovitz et al., 2017) thus leading to complex per-
sonalized responses to fear.
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lipid accumulation (Hanin et al., 2018).
At the translational level, miRs are ‘druggable’ entities, the impact
of which may be mitigated by suppressing targeted miRs via in-
travenous injection of synthetic antisense oligonucleotides (Mishra
et al., 2017). Thus, both the miR-132 related inflammation and the
hepatic lipid accumulation may be reversed by administration of syn-
thetic antisense oligonucleotides designed to be complementary to the
miR sequence (Hanin et al., 2018; Shaked et al., 2009). This, in turn,
suggests that anxiety- and fear-related cholinergic-regulating miRs are
causally involved in mediating brain-to-body messages, affecting both
mental and physiological parameters that are reversible and potentially
treatable.
The apparent involvement of miRs in regulating post-trauma brain
activity raises the need to validate the relevance of cholinergic sig-
naling as a developing therapeutic strategy. Correspondingly, a single
nucleotide polymorphism (SNP) disrupting interaction of the primate-
specific miR-608 with the AChE gene is associated with mild elevations
in trait anxiety and inflammation (Geula et al., 2014). This is accom-
panied by elevated blood pressure and brain AChE activities, indicating
mal-responsiveness of minor allele carriers to anti-AChE agent (Hanin
et al., 2018). However, carriers of the minor allele also show elevation
in prefrontal activity under stress, as measured by fMRI, suggesting that
they may avoid post-traumatic stress symptoms (Lin et al., 2016). This
highlights a possibility for other therapeutic options when attempting
to re-script traumatic memories with repeated exposure therapy
(Grunert et al., 2007), considering that a number of variables might
mediate the therapeutic effect of re-scripting- and/or exposure-based
therapies. Imbalanced miR-608 activities are yet more drastically evi-
dent under inherited disruption of miR-608 by a SNP in the miR itself.
This genomic change is associated with an increased risk of sepsis fol-
lowing head injury (Zhang et al., 2015), indicating a collapse of in-
flammatory regulation in minor allele carriers.
Considering the miR-regulated alterations following trauma, the
timeline aspects of fear-induced symptoms are of special interest, since
depression, for example, is known to associate with both immune
malfunctioning and a worsened course of diverse aging-related dis-
eases. This raises the possibility that during the post-reproductive and
evolutionarily “blind” years, chronic exposure to trauma may shorten
one's life span, compatible with the antagonistic pleiotropy hypothesis
(Wiilliams, 1957). Supporting this notion, depression, inflammation
and cholinesterase activities all increase with aging (Shenhar-Tsarfaty
et al., 2016). Moreover, metabolic syndrome patients with higher risk
to develop diabetes show increased circulating cholinesterase levels and
pulse values, and diabetic patients present simultaneous increases in
depression, inflammation and circulation cholinesterase activities,
suggesting that cholinergic impairment precedes depression. Taken
together, these findings indicate that a malfunctioning cholinergic
regulation weakens the otherwise protective link between depression
and the pathogen–host defense, with global implications for aging-re-
lated diseases.
Functional neuroimaging enables detection of processes that may
reflect the above-mentioned molecular processes. In the framework of
personalized neuropsychiatry, several main approaches should be taken
into consideration: task-related fMRI, resting-state fMRI, MR-spectro-
scopy and molecular neuroimaging. Task-related fMRI is well known in
the evaluation of cognitive function. A recently introduced approach
has combined virtual reality techniques into the fMRI-theater in order
to detect bodily-signals such as heart and respiratory rates (Allard et al.,
2017; Ronchi et al., 2017). These signals were mostly activating the
insular cortex and limbic system, in probable relation to their role in
reflecting emotional processes (Allard et al., 2017; Ronchi et al., 2017).
While task-related fMRI in general and VR-based specifically are
lengthy, labor intensive and require specialized settings, resting-state
fMRI has proven in the recent years to be easily applicable in a
5–10min recording session. Moreover, new computational tools enable
to extract brain-networks (such as memory, emotion, or attention
networks) and quantify their properties in both the gray (Yeo et al.,
2011) and the white (Peer et al., 2017) matter.
In the framework of neuropsychiatry, special importance should be
assigned to the DMN. The DMN comprises a set of brain regions which
process self-referential cognitive operations such as elaboration on
autobiographical memories, simulation of future occurrences or mind
wandering (Buckner et al., 2008; Raichle et al., 2001). As such, the
DMN has been implicated in several neuropsychiatric disorders (Zhang
and Rachle, 2010). Using resting-state fMRI, we were recently able to
demonstrate in patients with conversive paralysis, a stress-induced self-
related activity in the DMN that leads to an escalating cascade of events
in emotional, memory and body-processing networks, ending in al-
terations of the sensorimotor network (Monsa et al., unpublished ob-
servations). This cascade of events demonstrates how stress-induced
hyperactivity in the DMN leads, through neurocognitive operations, to
the clinical neurological bodily manifestation of paralysis. However,
integrating the molecular and large-scale neuro-circuit levels together is
still highly challenging. Several studies used MR-spectroscopy to show
elevation of N-acetyl-aspartate as well as choline activity in such cir-
cuits (Nacewicz et al., 1993). The nascent field of molecular MR ima-
ging may shed a new light on the interaction between neuro-cognition,
brain circuitry, and the molecular pathways involved.
While both neuro-genomics and neuro-cognitive studies of fear-re-
lated mechanisms of action have made major progress over the past
decade, major challenges lie ahead in the need to combine approaches
from different levels of the neurosciences – from molecular and cellular
levels to large-scale networks – into an integrative entity. Inter-in-
dividual variability, small group sizes and sampling difficulties all
contribute to these difficulties; nevertheless, a recent brain mapping
study shows early deterioration of cholinergic pathways in patients
with Alzheimer's disease (Schmitz et al., 2016), a condition associated
with behavioral alterations that include increased fear, and isolation of
exosomes enables quantification of microRNAs in plasma samples, in-
dicating that progress will soon be made also in these challenging
bridging efforts. As is often the case, breakthroughs depend on con-
vergent efforts that combine seemingly distinct fields of research into a
single entity.
4.5. Role of alterations in the perisynaptic environment in fear learning and
memory; identification of potential therapeutic targets
Synaptic adaptations of the brain in response to chronic stress have
consistently been demonstrated in animal models (McEwen et al.,
2016). Brain regions that are particularly involved include the hippo-
campus, amygdala and prefrontal cortex (Miller and McEwen, 2006).
An overview of the animal models thought to model aspects of PTSD is
beyond the scope of this review, but include stressors such as footshock,
underwater trauma and social defeat (Schoner et al., 2017). A recent
study in rats that investigated the effects of underwater trauma on ac-
tivity patterns in limbic regions found not only that patterns differ
between specific limbic (sub)regions, but also depend on the behavioral
phenotype that develops after trauma-induction (classified as anxious,
anhedonic or not-affected) (Ritov et al., 2016). Although technical
limitations prevent such detailed assessments in humans suffering from
PTSD, loss of hippocampal, amygdalar and anterior cingulate cortical
gray matter volume has been identified in PTSD patients and animal
models alike (Bennett et al., 2016; Meng et al., 2016). Of note, one
study that examined dendritic spines in PTSD-patients reported in-
creased numbers of immature dendritic spines in the ventral medial
frontal cortex (Young et al., 2015). Thus, while the expectation that
synaptic abnormalities are implicated in clinical PTSD is mostly based
on findings from animal models, clinical findings in PTSD-patients ap-
pear to suggest a similar underlying neuropathology and imply ab-
normalities in the (peri)synaptic environment.
Current pharmacotherapies for PTSD may work in part through
their action on synaptic connectivity. Antidepressants most commonly
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prescribed for treating PTSD raise the levels of BDNF and enhance
signaling through CREB whilst promoting synaptic growth and neuro-
genesis (Carlezon et al., 2005; Duman, 2004). The actions of the anti-
depressant ketamine on synapse formation (Li et al., 2010) are parti-
cularly interesting because, in contrast to other antidepressants,
ketamine functions very rapidly. The therapeutic effects of ketamine
were recently found to depend on early- and sustained activation of
AMPA receptors (AMPARs) (Zanos et al., 2016). This finding is in line
with the observation that surface diffusion of AMPARs is required for
both long-term potentiation (LTP) as well as contextual learning (Penn
et al., 2017). AMPAR surface diffusion can readily be affected through
protein-protein interactions, and this mechanism was thus suggested as
a possible target for the modulation of synaptic potentiation and
learning (Zanos et al., 2016).
A crucial factor in fear learning and memory is the role of context.
As described previously in this review, deficits in contextual processing
can lead to maladaptive inflexible behavior seen in a number of psy-
chiatric disorders, notably PTSD where out-of-context experiences ap-
pear to be at its very core (Maren et al., 2013). Hence, Contextual Fear
Conditioning (CFC) in rodents – as described in Section 3.1 – is a fre-
quently employed paradigm to study aspects of fear learning and
memory that are possibly related to the neuropathology of PTSD. CFC,
interestingly, has been found to affect neuronal integrity where sy-
naptic function appears to be particularly vulnerable. For example,
proteins relevant for LTP were linked to long-term memory formation
after CFC (Abel et al., 1997; Scharf et al., 2002). Furthermore, synaptic
protein degradation in the hippocampus was found to underlie the
destabilization of retrieved fear memory (Lee et al., 2008).
Cell adhesion molecules (e.g., integrins, immunoglobulin-like (Ig)
adhesion molecules and cadherins) in the brain connect pre- and post-
synaptic sites and may be disrupted by CFC, with serious consequences
for the maintenance of inter-cell stability and the preservation of sy-
naptic integrity. CFC was found to regulate hippocampal levels of the
cell adhesion molecules NCAM and L1 (both belong to the Ig-super-
family) depending on time and stressor duration (Merino et al., 2000).
NCAM can undergo a posttranslational modification that is implicated
in the neural mechanisms underlying long-term memory formation,
termed polysialylation (PSA), and is required for synaptic remodeling
(Nothias et al., 1997). Fear conditioning using a stressful 0.4mA sti-
mulus increased the number of PSA-NCAM+ neurons in the hippo-
campal dentate gyrus, whereas these numbers were reduced with a
more traumatic 1mA stimulus (Sandi et al., 2003). Furthermore, prior
application of chronic restraint stress in rats facilitates subsequent CFC.
These rats also displayed a reduced protein expression of NCAM in the
hippocampus although protein expression of PSA-NCAM was increased
(Sandi et al., 2001). The finding that CFC can be affected by a preceding
stressor is in line with the observation that stressful experiences can
trigger PTSD in susceptible individuals; moreover, hypercortisolemia
has been found in PTSD patients (Yehuda, 2001). In agreement, glu-
cocorticoid infusion into the hippocampus of mice was found to result
in PTSD-like memory impairments, as these animals became unable to
correctly identify the context as a threat predictor (Kaouane et al.,
2012). In corroboration with the link between hippocampal NCAM and
CFC specifically, intracerebroventricular infusion of C3d, a synthetic
peptide ligand that binds the Ig-like module of NCAM, was found to
attenuate the expression of CFC when administered few hours post-
training (Cambon et al., 2003). The evidence that the effects of a pre-
existing stressor on CFC may be mediated through altered expression of
cell adhesion molecules and/or their posttranslational modifications
opens up the possibility to design putative treatment strategies.
Nectins are, akin to NCAMs, Ig-like adhesion molecules with four
known subtypes (1–4). Nectins aggregate in the brain at puncta ad-
herentia junctions, sites that connect pre-and postsynaptic membranes
(Takai et al., 2008). Nectin-1 is involved in CFC; protein levels of
nectin-1 were increased in the synaptic fraction of ventral hippocampal
matter following CFC (Fantin et al., 2013). The importance of nectin-1
specifically in the ventral hippocampus for the expression of CFC was
confirmed by local infusion of R165, an anti-nectin-1 antibody serum
that interferes with nectin-1 function. R165 infusion into the ventral
hippocampus immediately after CFC reduced fear memory consolida-
tion, as shown by reduced fear response when tested two- and seven
days later, but these effects were not seen when R165 was infused into
the dorsal tier (Fantin et al., 2013). CFC did not affect the expression of
hippocampal nectin-3 in this study. However, since hippocampal
nectin-3 is strongly involved in the effects of other types of stressors,
including chronic restraint and early life stress, on learning and
memory (van der Kooij et al., 2014; Wang et al., 2013, 2017), the
possibility that the initial expression of hippocampal nectin-3 may be
important as priming a condition for subsequent learning and memory
related to CFC should not be overlooked.
Intra-synaptic processes are also expected to play an important role
in the pathogenesis of PTSD. A recent report on a genome-wide DNA
methylation study performed on the peripheral blood from combat
veterans describes the investigation into underlying biological path-
ways based on the genes that were significantly associated with PTSD
symptom severity (Mehta et al., 2017). The most notable pathway that
emerged from this study involved regulation of the actin skeleton. In-
terestingly, another study showed that gene expression levels of an
actin nucleator, Formin 2, were strongly reduced in peripheral blood
from PTSD patients (Agis-Balboa et al., 2017). Cerebral actin dynamics,
governed by actin binding proteins, are central mechanisms that de-
termine the shape and function of synapses (Cingolani and Goda, 2008).
It remains to be determined, though, to what extent the findings in
peripheral blood of PTSD-patients (Agis-Balboa et al., 2017; Mehta
et al., 2017) can be extrapolated to the brain. Impaired actin dynamics
could explain the abnormal dendritic spine morphology found in the
PTSD brain (Young et al., 2015) and be an important contributing
factor underlying PTSD neuropathology. Several actin binding proteins
have been identified that are directly regulated by stress and stress-
related effectors, such as glucocorticoids and corticotropin-releasing
hormone, incorporating the integral importance of stress in the neu-
robiology of PTSD (van der Kooij et al., 2016).
While an understanding of PTSD pathogenesis is important for the
development of possible therapeutics, the ability to predict PTSD vul-
nerability factors could allow implementation of preventive measures.
Identified vulnerability factors found in PTSD-patients include, among
others, a dysregulation of the glucocorticoid-signaling pathway and
single nucleotide polymorphisms at the glucocorticoid receptor and
FKBP5 genes (van Zuiden et al., 2013). Therefore, these clinical find-
ings, which suggest that abnormal regulation of the stress-regulating
HPA axis may predispose individuals to an increased risk for developing
PTSD, are congruent with the significance of pre-stressors and stress
dysregulation in animal models for PTSD (Kim et al., 2013a, 2013b).
4.6. Treatment of fear memory disorders in humans; use of VR paradigms
4.6.1. Exposure therapy
Exposure therapy (ET) has proven effective in the treatment of an-
xiety disorders (Deacon and Abramowitz, 2004; McNally, 2007).
During ET, the patient is repeatedly confronted with the feared object
or situation until his/her distress level decreases (Bentz et al., 2010;
Richard and Lauterbach, 2011). ET may be performed in vivo or in sensu
(Craske et al., 2014). Moreover, Virtual Reality Exposure Therapy
(VRET), i.e. confronting patients with their feared stimuli in Virtual
Reality (VR), has successfully been implemented in treating anxiety
disorders (Freeman et al., 2017; Opriş et al., 2012; Powers and
Emmelkamp, 2008). VRET goes well with the emotional processing
theory proposed by Foa and Kozak (1986), which suggests that, after
being confronted with feared stimuli, the fear network is activated and
can be modified by incorporating new, incompatible information into
the network (Parsons and Rizzo, 2008). Furthermore, VRET puts special
emphasis on perceptual cues, which have been shown to play a major
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role in phobic fear (Shiban et al., 2016).
Being as effective as in vivo exposure (Anderson et al., 2003;
Emmelkamp et al., 2002; Powers and Emmelkamp, 2008), VRET offers
several advantages. A major advantage is the fact that the therapist can
control the intensity, frequency and pace of the exposure, thus adapting
the exposure to fit the patient's needs (Diemer et al., 2014). Being de-
livered in the therapist's office, VRET is not only performed in a safe
environment but also offers considerable organizational and cost ad-
vantages (Emmelkamp, 2005; Opriş et al., 2012). Furthermore, phy-
siological parameters like heart rate and skin conductance response
(Diemer et al., 2014) as well as behavioral parameters (see Mühlberger
et al., 2008) can easily be measured during VRET, thereby improving
clinical assessment. With respect to the patients’ attitudes toward
treatment, acceptance is higher for VRET than for in vivo exposure
(Garcia-Palacios et al., 2007).
4.6.2. How is VR used in treatment? Head mounted display and computer
automatic virtual environment
During VRET, the virtual environment is presented to participants
with the help of a head mounted display (HMD) or a computer auto-
matic virtual environment (CAVE) (Krijn et al., 2004). A HMD (see
Fig. 8) includes screens for both eyes, display optics, headphones and a
tracking device for monitoring the participants’ head position.
Throughout exposure, the therapist can view the virtual environment
presented to the patient via a user interface on a computer screen.
The CAVE (see Fig. 8 right) consists of a cubicle with the virtual
environment being projected to its sides (Krijn et al., 2004). Both the
patient and the therapist are inside this cubicle during exposure therapy
(see Fig. 8 right).
4.6.3. Evidence
Being as effective as in vivo exposure, VRET has successfully been
used in treating anxiety disorders (Opriş et al., 2012; Powers and
Emmelkamp, 2008). VRET has proven effective in treating specific
phobia like arachnophobia (Shiban et al., 2013), acrophobia
(Emmelkamp et al., 2002; Krijn et al., 2004) or aviophobia (Cardoş
et al., 2017; Mühlberger et al., 2003). As for in vivo exposure (see Öst
et al., 1997), there is evidence to show that a single session of VRET can
produce significant treatment effects (Mühlberger et al., 2003). Fur-
thermore, VRET has successfully been used in the treatment of panic
disorder (Botella et al., 2011), social phobia (Anderson et al., 2003;
Klinger et al., 2005) and PTSD (Difede et al., 2007; Rothbaum et al.,
2001). Overall, a significant expansion of VR in psychotherapeutic
practice and clinical contexts is expected (Diemer et al., 2015).
4.6.4. Special issues related to VR therapy: immersion and presence
Immersion and presence are two closely related but distinct con-
cepts (Price et al., 2011). Immersion refers to technical aspects (field of
view, display resolution) of the system used, i.e. its capability to re-
present the real world with respect to different modalities (Krijn et al.,
2004; Slater, 2003). Immersion influences presence, which refers to the
extent to which individuals perceive the virtual environment as real and
feel connected to it (Krijn et al., 2004; Price et al., 2011; Schubert et al.,
2001). Research suggests that presence is important but not sufficient
for successful VRET (Diemer et al., 2015; Price and Anderson, 2007).
4.6.5. Limitations
VRET fails to induce anxiety in some patients which may impede
treatment efficacy (Anderson et al., 2005; Diemer et al., 2014). VR
sometimes causes nausea, dizziness, or headache (Bush, 2008). In order
to prevent simulator sickness, the VR has to be designed appropriately
and patients susceptible to motion sickness should not undergo VRET
(Hoffman et al., 2001). Furthermore, keeping exposure short
(< 20min) or providing breaks during the sessions could reduce the
risk of simulator sickness (Gujjar et al., 2017; Hoffman et al., 2001).
Lastly, even though VRET has proven effective, it is rarely used in
practice to date. Therapists may be reluctant to use VR due to high costs
for purchasing the devices needed, or because they are not familiar with
the intervention methods (Rothbaum et al., 2000).
4.6.6. Outlook
There are several technological innovations VRET might benefit
from. With the help of physiological measures or movement tracking,
the virtual environment could automatically be adapted in a way that
fosters treatment outcome (Lindner et al., 2017). Furthermore, using
augmented reality (i.e. virtual objects, such as feared stimuli, being
integrated into the patient's perception of the real environment) may
increase the feeling of presence during exposure as well as the ecolo-
gical validity of VRET (Baus and Bouchard, 2014; Botella et al., 2011;
Dünser et al., 2011). Finally, it is important to provide affordable and
user-friendly devices in addition to training programs for therapists in
order to foster clinicians’ acceptance of VRET (Botella et al., 2017).
5. Use of autobiographical memory for coding, diagnosis, and
treatment of fear memory disorders
5.1. Coding of earliest fear-related memories, as part of autobiographical
memory
From an evolutionary perspective, the precise coding of a threa-
tening event is important in order to be prepared for future threats.
From a very early age, humans are programmed to use emotional in-
formation to understand potentially threatening situations. A number of
studies have shown that as early as 6–12 months of age, infants start to
display an attentional bias toward fearful facial expressions (Leppänen
and Nelson, 2009; Peltola et al., 2012). During the life course, events
that are credited as more important during encoding are better re-
membered over time (Wittmann et al., 2005). In general, emotional
information is often better remembered than neutral information.
Arousal response, often related to the emotional events, elicit emotion-
Fig. 8. Left panel. Head mounted display (HMD) and virtual environment presented. Right panel. Example of the CAVE paradigm. Figure adapted from Fig. 1 in Pinna
(2018).
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specific processes, which enhance both encoding, consolidation and
retrieval of event-related memory (Kensinger, 2009). Emotionally
arousing experience results in the engagement of adrenergic and cor-
tisol stress-hormone systems in the amygdala that interact to promote
memory storage in the cortex (McGaugh, 2004). On the other hand,
under conditions of severe stress, people may focus almost exclusively
on survival and endurance, and the attentional focus is narrowed. This
can result in poor memory for the events that elicited emotion
(Deffenbacher et al., 2004).
The most important episodes in life constitute the autobiographical
memory, “the explicit memory for specific points in the past, recalled
from the unique perspective of the self in relation to others” (Nelson
and Fivush, 2004).
It starts to develop at the age of 5–6 years and earliest memories are
regarded as integral parts (Nelson and Fivush, 2004; Peterson et al.,
2005). Episodic autobiographical elements, such as reference to oneself
as a part of the memory and emotionally significant events, develop
later than semantic autobiographical memory, which is knowledge that
the events happened (Piolino et al., 2007). It is noteworthy that re-
viewing the contents of certain events (i.e. episodic memory) enhances
the memory of those events (Finley et al., 2011; Koutstaal et al., 1998).
Therefore, early memories that are frequently discussed and reviewed
with a parent, for example, are strengthened.
The research is quite unanimous about the fact that people cannot
remember events from their first three years of life, and that memories
will become inaccessible later on, which eventually results in childhood
amnesia (Peterson et al., 2009; Tustin and Hayne, 2010). A core pre-
condition for verbal recollection of an experience is sufficient linguistic
capacity at the time of encoding a memory (Morrison and Conway,
2010; Nelson and Fivush, 2004). Simcock and Hayne (2002) observed
that children could not verbally report information about an event that
they had experienced at the age of 2–3 years if it involved issues that
were not yet part of their productive vocabulary.
However, intensive fear and prolonged stress might have an impact
on the formulation of very early memories. The study with a non-
human sample by Callaghan and Richardson (2012) showed that rat
pups experiencing a stress response from early maternal separation had
enhanced early memories for fear: rat pups subjected to maternal se-
paration early in their development responded with longer retention of
fear memories formed during infancy in comparison to the non-stressed
control group. Callaghan and Richardson concluded that adverse en-
vironments in infancy lead to longer retention of childhood memories.
They also concluded that this reflects an early transition into the adult-
like memory system, an effect that is mediated by exposure to the stress
hormone corticosterone, the rodent form of cortisol. This offsetting
effect of a stress response related to parental separation on childhood
amnesia has not yet been demonstrated in human children. However, it
has been observed that people with prolonged childhood maltreatment
elicit elevated levels of fear and anxiety as a response to the script-
driven imagery of personalized trauma narratives (Lanius et al., 2001,
2003) as well as to the standardized scripts focusing on arousal of safety
concerns (McTeague et al., 2010). Especially, anxious people are likely
to have anxiety-related memory bias of events that have ambiguous
meaning, eliciting emotional interpretation (MacLeod and Mathews,
2004).
Fear as an emotion can both enhance the encoding of certain parts
of an event and narrow the encoding of other parts, as mentioned
briefly above. First, “tunnel memory,” or the emotional memory nar-
rowing (Kensinger, 2009), happens when increasing emotional arousal
results in attention narrowing to features that are of central importance
to events; later on, these details are more strongly remembered. At the
same time, peripheral details are not encoded (Christianson and Loftus,
1991). The phenomenon of earliest memories becomes even more
complex when looking at the evidence showing that memories may
include errors concerning when an event happened, what happened,
where it happened, and who was involved. It is also possible that a
person “remembers” totally false events – even childhood sexual abuse
– if he/she is exposed to misleading information (Loftus and Bernstein,
2005; McNally et al., 2004).
Remembering is always a process of mental reconstruction, meaning
that current challenges and stressful events can influence what we re-
member (Conway, 2005). According to the Self-Memory System model
of autobiographical memory, memories that are coherent with and
confirm one's goals and self-images are more accessible. This could be
why earliest fear-related memories do not have same importance to all
individuals. Interestingly, “only” a third of war-affected Palestinian
children reported traumatic events and accidents as their earliest
memory, while 43% reported pleasant memories of play and nice places
(Peltonen et al., 2017). Their occurrence closely corresponds with
earliest memories in studies among children living in peaceful and safe
environments (Mullen, 1994). This might be interpreted as evidence for
individual trajectories concerning the significance of earliest fear-re-
lated events as a part of autobiographical memory.
Empirical evidence of gender differences on children's auto-
biographical memories is mixed. Some studies show that girls report
more traumatic situations and more significant transitions (Peterson
et al., 2005) with more narrative, coherent, and longer descriptions
(Tizzard-Drover and Peterson, 2004). Others show no significant gender
differences in the content or structure of children's autobiographical
memories (e.g., Burgwyn-Bailes et al., 2001; Fivush et al., 2008).
Taken together, it can reasonably be assumed that the earliest fear-
related events would be central parts of human autobiographical
memory. Due to childhood amnesia and mental reconstruction of
memories, it is, however, extremely difficult to study the prevalence or
centrality of such events. More research of fear and autobiographical
memory is needed, especially among children, as we know that access
to early childhood memories becomes more difficult with age.
5.2. Autobiographical memory in affective disorders, including fear-related
disorders
The concept of episodic memory was originally coined by Tulving
(1972), and although there is still no general consensus pertaining to
the core components of episodic memory (Zlomuzica et al., 2014),
autobiographical memory (AM) is considered as a specific type of epi-
sodic memory that involves the recollection of an individuals’ personal
experiences of specific events. In accord with Conway and Pleydell-
Pearce's (2000) model, AMs are organized via a hierarchical three-
tiered structure, ranging from (1) broad lifetime periods, (2) more
general events, and (3) event specific knowledge; the latter includes
specific episodic memories. This enables an individual to retrieve per-
sonally relevant information using different levels of abstraction. A
large body of literature has demonstrated that individuals with de-
pressive-, stress- and fear-related disorders are vulnerable to exhibiting
impaired episodic autobiographical memories (e.g., Airaksinen et al.,
2005; Griffiths and Lovick, 2005; Williams et al., 2007). Importantly,
affective disorders, including fear-related disorders, lead to disruptions
in the hierarchical search process resulting in over-general memories
(Griffith et al., 2012; Hitchcock et al., 2017). Over-general auto-
biographical memory (OGM) is associated with a number of emotional
disorders, particularly depression, trauma and stress-related disorders
(e.g., Kangas et al., 2005; Moore and Zoellner, 2007; Moradi et al.,
2014; Williams et al., 2007). However, evidence for OGM is more
variable for other types of fear disorders (Hitchcock et al., 2017; Wenzel
et al., 2004). OGM is characterized by difficulties in the retrieval of
specific personal memories. Notably, individuals with OGM deficits
retrieve more generic or broad-based memories that cover an extended
period of time. They are also susceptible to retrieving more categorical
memories (e.g., ‘taking baths is a relaxing time for me’). Importantly,
OGM is a unique facet of cognition as this memory deficit is not fully
explained by generalized memory deficits or lower IQ (Griffith et al.,
2012).
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Conceptual models (Beck and Clark, 1997; Ehlers and Clark, 2000;
Foa and Kozak, 1986) and empirical studies suggest that the suscept-
ibility of individuals with affective disorders to bias toward over-gen-
eral processing of autobiographical information is a protective me-
chanism, as this facilitates avoidance associated with negative
emotional experiences (Wenzel et al., 2004). Fear-related disorders also
lead to biases toward negative valence memories with reduced access to
positive valence memories.
5.2.1. Assessment and coding of autobiographical memory functioning
A number of methods have been utilized to assess AM functioning,
including the detection of OGM deficits (for review, see Griffith et al.,
2012). To date, the most commonly used AM assessment paradigm is
the Autobiographical Memory Test (AMT). The AMT was developed by
Williams and Broadbent (1986): in their seminal work, they found that
suicidal patients retrieved significantly more over-general memories
compared to both clinical and healthy controls. The AMT is a cuing
paradigm and currently considered the ‘gold standard’ measure of AM,
with adequate psychometric properties (Griffith et al., 2012).
The AMT involves presenting a combination of positive valence
(e.g., ‘happy’) and negative valence (e.g., ‘sad’) stimulus cue words, and
the individual is asked to elicit the first specific personal memory that
comes to mind. Some studies have also used neutral cue words (e.g.,
‘beach’). A specific memory is defined as a particular event that oc-
curred at a specific time and place. For example, a specific memory to
the cue ‘excited’ could be ‘I was very excited last Sunday when one of
my closest friends from overseas visited me.’ Typically, no time period
restrictions are provided; that is, the specific memory can occur from
any time period in a person's life, referred to as ‘unconstrained AM.’
However, some experimental studies have used the AMT by imposing a
‘constrained memory’ period; in particular, asking participants to gen-
erate specific memories in response to a restricted period in their life
(e.g., ‘since the time you were diagnosed with cancer’; Kangas et al.,
2005). Participants are also required to retrieve a new specific memory
in response to each cue word presented – repeat memories are not
coded as specific memories.
Five type of coding categories are typically used with the AMT,
including the proportion of (1) specific memories retrieved; (2) ex-
tended memories which go beyond a single day; (3) categorical mem-
ories; (4) semantic associations, and (5) omissions (i.e., no general or
specific memory is generated within the set time period). Latency of
response is also coded; specifically, the time taken to generate the first
specific memory to the stimulus cue within the allotted time period is
recorded. Typically, individuals have 30 to 60 s to generate a specific
memory, with some variability between studies (Griffith et al., 2012).
Feedback is usually not provided to individuals during testing. How-
ever, some studies have used prompting if a specific memory is not
initially reported within the allotted time.
Over the last decade, a number of variations to the AMT have been
tested. These include a minimal instructions version (Debeer et al.,
2009), the Sentence Completion for Events of the Past Test (SCEPT;
Raes et al., 2007) and the TEMPau (the Test Episodique de Memoire du
Passe autobiographique; Piolino et al., 2009) (for review, see Griffith
et al., 2012). Given the variability of formats available for the AMT, this
may partially explain the mixed findings in the literature pertaining to
which individuals are more vulnerable to experiencing AM deficits (e.g.,
D’Argembeau et al., 2006; Morgan, 2010; Wenzel et al., 2004). In
particular, variability exists between AMT protocols administered in
terms of types of coding categories used; stimulus cue format (verbal/
oral vs. visual or both); type of cue words and types of valence tested
(i.e., negative, positive vs. neutral cues) as well as number of cues used;
and format of testing (computer generated cues vs. face to face).
Wenzel et al. (2004) proposed that there is variability in the types of
anxiety-related memories activated between specific types of anxiety
disorders, which may further explain the mixed findings that have
emerged in studies investigating memory biases toward threat in
individuals with fear disorders. Notably, PTSD and panic disorder (PD)
consist of memories that have more salient and vivid properties com-
pared to memories based on more social and generic worries as defined
by Generalized Anxiety Disorder (GAD) and social anxiety disorder
(SAD). In fact, Wenzel et al. (2004) found some support for this pro-
position, as trauma-related memories were reported to be most vivid
and more likely to generate intense negative emotions relative to gen-
eralized worry and social-related memories. They further posit that
PTSD and PD are associated with events that are more fear provoking
and unexpected, which may contribute to activating memories that are
more vivid and sensory in detail relative to more generic and social-
oriented experiences. Indeed, there is evidence to further support this
latter proposition. Studies have shown that individuals with PTSD ex-
perience vivid and sensory recollections of their traumatic experience,
which facilitates the maintenance of this disorder by way of avoiding
cues that activate trauma-induced memories. Moreover, impaired re-
trieval of specific trauma-related memories within the initial month
post-trauma have been found to be predictive of PTSD severity overtime
(e.g., Harvey et al., 1998; Kangas et al., 2005). Conversely, there is
evidence that indicates individuals with SAD recollect past social ex-
periences with more self-referential information but less vivid sensory
information (including visual and auditory details), contributing to
distorted self-perceptions and disrupting processing of past social ex-
periences, thus facilitating the maintenance of SAD symptoms
(D’Argembeau et al., 2006; Morgan, 2010). Taken together, this body of
literature indicates that affective disorders are associated with AM
deficits, although there is variability in the specific type of deficits
elicited contingent on whether the memory is associated with a trauma
or intense fear-related event rather than more general, diffuse and so-
cially-oriented experiences. This has implications in terms of treatment
interventions that have been developed to specifically target AM
training.
5.2.2. Treatment of AM in fear disorders
Over the past decade, several novel cognitive-based interventions
have been developed which focus on targeting OGM deficits, referred to
as ‘autobiographic episodic training’ (AET). Hitchcock et al. (2017)
define AET as ‘any training protocol that targets either retrieval of past
autobiographical episodes or projection of future autobiographical
episodes, with the aim of modifying processing biases (e.g., over-
generalization, reduced salience of positive material)’ (p. 94). There are
several different types of AET programs which have been developed to
date, including Memory Specificity Training (MEST; Raes et al., 2007),
Concreteness Training (Watkins et al., 2009), Competitive Memory
Training (COMET; Ekkers et al., 2011); and variations of the Cognitive
Bias Modification (CBM) paradigm. The MEST, COMET and concrete-
ness training have all been initially tested with depressed samples. This
is not surprising, given that OGM is a robust finding in the depressive
literature over the past three decades. More recently, the efficacy of
MEST, COMET and variants of the CBM have been tested with trauma
and anxiety samples.
The MEST, which was developed by Raes et al. (2007), is a 4-session
group training intervention in which individuals are required to prac-
tice recalling specific memories in response to negative, positive or
neutral cue words over a 4-week interval. Psychoeducation is an initial
component of this program, whereby participants are introduced to the
different types of AM categories (i.e., extended, categorical and spe-
cific). The MEST also includes structured homework based on repeated
practice of generating specific memories to cue words to enable gen-
eralization of skills to daily experiences.
Watkins and Moberly (2009) designed the 6-week concreteness
training paradigm with the objective to improve individuals to recall
specific negative daily experiences in a more concrete way by com-
pleting a series of daily training exercises. Imagery is used as part of this
process specifically to focus on the sensory detail of recollected ex-
periences.
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The COMET program was developed by Ekkers et al. (2011) and has
also been tested in group format, typically in 7–8 sessions. The aim is to
learn to preferentially recall positive memories. This is based on Bre-
win's theory of competitive memory retrieval hierarchies (Brewin,
2006), focusing on changing access to more positive material relative to
negative memories facilitated by use of imagery and positive self-ver-
balizations. A number of COMET protocols have been developed for
specific psychopathologies, including changing memory representa-
tions associated with worry, rumination and self-esteem (for review, see
Hitchcock et al., 2017).
Variations of the CBM paradigm have been tested to improve AM
functioning by utilizing imagery-based CBM. This involves practicing
imagining more positive outcomes for ambiguous scenarios presented.
In particular, the aim is to train individuals toward a more positive bias
in recollecting positive outcomes for ambiguous events whilst also
training individuals to generate more positive specific outlooks for the
future (e.g., Lang et al., 2012).
Hitchcock et al. (2017) recently published a meta-analytic review
based on evaluating 15 randomized controlled trials (RCTs) that compared
an AET program to a control condition in adult samples with a clinician-
derived major depressive disorder (MDD) or anxiety and stress-related
disorder. The majority of the trials identified (n=12) tested the efficacy
of the AET paradigm with individuals with MDD, whilst two studies were
based on samples with anxiety disorders, and one study used a sample of
individuals diagnosed with PTSD. A small effect was found for the efficacy
of AET on depressive symptoms for MDD samples (d=.32), with the
strongest evidence for COMET (although this is in part due to more studies
to date having tested COMET relative to other types of AET paradigms).
The two anxiety-based AET studies also utilized the COMET paradigm –
one with an Obsessive Compulsive Disorder (OCD) sample (Schneider
et al., 2015), and the other with individuals with PD (Korrelboom et al.,
2014). In the OCD study, no differences in change of OCD symptoms were
found for the COMET relative to control condition. In the PD study, the
COMET was compared to a group-based Applied Relaxation program, and
both programs were found to be significant in reducing panic symptoms
with no differences evident between groups. The only RCT identified for
stress-related conditions was based on a small sample of 24 Iranian combat
veterans with PTSD who either received MEST for 5-sessions or were
randomized to a no-intervention control condition (Moradi et al., 2014).
Findings revealed support for the MEST program, with participants re-
porting significant reductions in PTSD symptoms as well as improvements
in specific memory recall, persisting at a 3-month follow-up mark.
Collectively, for fear disorders, the AET paradigm is very much in its
infancy. Although the outcomes from the Moradi et al. (Moradi et al.,
2014) and Korrelboom et al. (Korrelboom et al., 2014) studies are
promising, more research using larger samples is clearly warranted.
Taking into account the MDD studies, Hitchcock et al. (2017) conclude
that the current evidence for AET for MDD is of moderate strength, but
more research is needed to establish whether AET is efficacious as a
standalone treatment, or whether it is more efficacious when included
as a module of more established treatments for depression. This re-
commendation would also eventually extend to fear-related disorders.
Moreover, in accord with Hitchcock et al.’s (2017) recommendations,
the possibility of integrating components of AET programs to simulta-
neously target both improving memory bias and specificity whilst also
enhancing positive memory retrieval and generation of future projected
expectancies is a fruitful avenue for future intervention studies in this
field. This line of inquiry has direct relevancy for fear disorders given
these are maintained by fear of recurrence and/or biased expectations
of future experiences.
6. Linguistics
With this understanding of the current state of anxiety and fear
research as a backdrop, our team was specifically tasked to review the
language that people use to express feelings related to anxiety and fear.
Within the realm of affective research, confusion arises over the fact
that some feelings are a component/constituent of emotional responses.
For example, fear as an emotion consists of a continuum of auto-
matically activated defense behaviors (Kozlowska et al., 2015) that co-
occur along with “feelings of fear”. Consequently, the term feeling is
often used incorrectly as a synonym for emotion and vice versa (LeDoux,
2015a; Munezero et al., 2014). But feelings are not emotions per se
(LeDoux, 2015b) which tend to be more complex (Fontaine et al.,
2007), and feelings are not limited to those that co-occur with specific
emotions. Rather, feelings encompass a wide range of important mental
experiences such as signifying physiological need (e.g., hunger), tissue
injury (e.g., pain), optimal function (e.g., well-being), the dynamics of
social interactions (e.g., gratitude), etc. (Damasio and Carvalho, 2013)
Additional challenges relate to the fact that feelings are not consistently
defined, and that our definitions for these terms can evolve over time
(Tissari, 2016). Moreover, while some feelings may be universally ex-
perienced across cultures (e.g., hunger, pain, cold, fatigue, etc.), other
feelings are understood to be culturally constructed (e.g., gratitude
(Boiger and Mesquita, 2012), optimism (Joshi and Carter, 2013)). As a
result, the Human Affectome Project taskforce agreed that any attempt
to create a linguistic inventory of articulated feelings would need to
first define feelings in a manner that can help us understand the full
range of terms to be considered and then undertaken with an acute
awareness that variations in terminology are going to exist in day-to-
day usage, between languages, and across cultures. So, a definition for
feelings was developed as part of the project. A small task team within
the larger effort reviewed the literature to create a definition for feel-
ings that could serve as a starting point. The task team produced a first
draft and shared it with the entire taskforce of nearly 200 researchers,
feedback/input was gathered, and then it was refined, redistributed and
the process iterated several times to achieve broad consensus within the
group. The resulting definition is as follows:
A “feeling” is a fundamental construct in the behavioral and neu-
robiological sciences encompassing a wide range of mental pro-
cesses and individual experiences, many of which relate to homeo-
static aspects of survival and life regulation (Buck, 1985; Damasio
and Carvalho, 2013; LeDoux, 2012; Panksepp, 2010; Strigo and
Craig, 2016). A broad definition for feeling is a perception/appraisal
or mental representation that emerges from physiological/bodily
states (Damasio and Carvalho, 2013; LeDoux, 2012; Nummenmaa
et al., 2014), processes inside (e.g., psychological processes) and
outside the central nervous system, and/or environmental circum-
stances. However, the full range of feelings is diverse as they can
emerge from emotions (Buck, 1985; Damasio and Carvalho, 2013;
Panksepp, 2010), levels of arousal, actions (Bernroider and
Panksepp, 2011; Gardiner, 2015), hedonics (pleasure and pain)
(Buck, 1985; Damasio and Carvalho, 2013; LeDoux, 2012;
Panksepp, 2010), drives (Alcaro and Panksepp, 2011), and cogni-
tions (including perceptions/appraisals of self (Ellemers, 2012;
Frewen et al., 2013; Northoff et al., 2009), motives (Higgins and
Pittman, 2008), social interactions (Damasio and Carvalho, 2013;
Gilam and Hendler, 2016; LeDoux, 2012; Panksepp, 2010), and both
reflective (Holland and Kensinger, 2010) and anticipatory perspec-
tives (Buck, 1985; Miloyan and Suddendorf, 2015)).
The duration of feelings can vary considerably. They are often re-
presented in language (Circanski et al., 2012) (although they can
sometimes be difficult to recognize and verbalize) and some feelings
can be influenced/shaped by culture (Immordino-Yang et al., 2014).
Feelings that are adaptive in nature (Izard, 2007; Strigo and Craig,
2016) serve as a response to help an individual interpret, detect
changes in, and make sense of their circumstances at any given point
in time. This includes homeostatic feelings that influence other
physiological/body states, other mental states, emotions, motives,
actions and behaviors in support of adaptation and well-being
(Damasio and Carvalho, 2013; Strigo and Craig, 2016). However,
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some feelings can be maladaptive in nature and may actually com-
pete and/or interfere with goal-directed behavior.
A “feeling” is not a synonym for the term “emotion”. There is
standing debate between researchers who posit that discrete emo-
tion categories correspond to distinct brain regions (Izard, 2010)
and those who argue that discrete emotion categories are con-
structed of generalized brain networks that are not specific to those
categories (Lindquist et al., 2012). However, both groups acknowl-
edge that in many instances feelings are a discernable component/
constituent of an emotional response (which tends to more com-
plex).
Using this definition of feelings as a starting point, the linguistics
task team then undertook a formal linguistic analysis and ultimately
proposed nine broad categories of feelings (i.e., Physiological or Bodily
states, Attraction and Repulsion, Attention, Social, Actions and
Prospects, Hedonics, Anger, General Wellbeing, and Other).
Feelings related to anxiety and fear were found in the Actions and
Prospects category which was described as “Feelings related to goals,
tasks and actions (e.g. purpose, inspired), including feelings related to
planning of actions or goals (e.g., ambitious), feelings related to readiness
and capacity of planned actions (e.g. ready, daunted), feelings related to
levels of arousal, typically involving changes to heart rate, blood pressure,
alertness, etc., physical and mental states of calmness and excitement (e.g.
relaxed, excited, etc.), feelings related to a person's approach, progress or
unfolding circumstances as it relates to tasks/goals within the context of the
surrounding environment (e.g. organized, overwhelmed, surprised, cautious,
etc.), feelings related to prospects (e.g. afraid, anxious, hopeful, tense, etc.)”
We reviewed the feelings found in this category of this linguistics
analysis and conducted a review of this language that people use to
convey feelings related to anxiety and fear.
6.1. Value of the development of linguistic tools for assessments and
treatment of fear learning and memory disorders
As described in the last three sections, subjective experiences and
autobiographies are valuable for analyzing fear and fear-related mem-
ories across people. In addition, these analyses would be valuable for
longitudinal analyses in individual clients or patients and to measure
response to behavioral and/or pharmacological interventions. They
could be used to assess fear and fear-related memories in individuals as
part of challenging missions, such as deep space missions of astronauts.
Thus, we suggest that linguistic analysis should be further developed
and incorporated into standard care.
One approach to analyze autobiographical writings could be using
an unbiased approach exploring relationships between words – either
words that occur together within 2–4 words or words that are being
used in the same text. For example, “tidytext” offers methods for cal-
culating and visualizing relationships in a given sample (https://www.
tidytextmining.com/ngrams.html). Interestingly enough, this approach
resembles the kind of analysis being used in systems biology to assess
relationships in large sets of biological data, seen in work from re-
searchers like Ovidu Iancu at the Portland V.A. Medical Center and
OHSU.
In contrast to the unbiased approach, text analysis could be biased
and based on the presence of specific words related to fear. The words
initially categorized as pertinent to anxiety and fear in this project were
categorized by the co-authors in one of the following categories: (1)
safety - internal; (2) safety - external; (3) anxiety - internal; (4) anxiety -
external; (5) fear - internal; (6) fear - external; or (7) other. In addition,
each word was rated using the following scale of intensity: 1: very mild;
2: mild; 3: medium; 4: strong; and 5: very strong. Realizing that being a
native English speaker or not might affect the categorization and in-
tensity ratings of these words (see also the section below regarding the
importance to consider cross-cultural issues regarding language and
feelings), we compared the responsive of the native and non-native
English speaking co-authors.
For the intensity ratings, we first ran a repeated measures ANOVA
comparing the rankings identified by native and non-native English
speakers; from this, we found significant main effects of word
(p < 0.0001, F(41,574)= 16.14), speaking status (p < 0.05, F
(1,14)= 5.459), and a significant interaction of speaking status and
word (p < 0.01, F(41,574)= 1.780). We then divided the analysis in
words rated between 1–3 and 3–5 separately and used a repeated
measures ANOVA. For the less severe-rated words (rated between 1–3),
analysis revealed a main effect of word (F(20,278)= 2.106, p < 0.01)
and an overall significant difference between native and non-native
speakers (F(1,278)= 48.93, p < 0.0001). There was a distinct group
of words that were rated with higher intensities by non-native speakers,
such as “disquietude” and “eerie” (Fig. 9A). For the other words rated
Fig. 9. Intensity rating of low-intensity (A) and high-intensity (B) words of native and non-native English speakers.
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between 1–3, there were no differences in mean ratings between the
groups (Table 3A). For the more severe-rated words (rated between
3–5), the opposite pattern was seen, with native speakers rating specific
words higher, such as “alarm” (Fig. 9B). For the other words rated
between 3–5, there were no differences in mean ratings between the
groups (Table 3B). Importantly, none of the words that were part of the
set for which a group difference was seen in either the 1–3 or 3–5 severe
range were unfamiliar to non-native speakers. In contrast, some of the
words for which there were no group differences, like “queasy,” were
less or not familiar among non-native speakers.
For comparing the categorization of the words in native and non-
native speakers, we collaborated with co-author Dr. Jessica Minnier, a
biostatistician at OHSU with special expertise in the analyses of large
data sets. The relative distance between (1) safety internal; (2) safety
external; (3) anxiety internal; (4) anxiety external; (5) fear internal; and
(6) fear external was discussed and agreed upon by co-authors Boutros
and Raber (Table 4). Subsequently, this information was used to com-
pare the distance of the categorized words for each co-author who
contributed feedback for this analysis. Potential group differences were
assessed comparing the distances between words of native and non-
native speakers using generalized estimating equation (GEE) regression,
which is often used to analyze correlated response data. As a control,
we compared the distances between words of two computer-generated
randomized groups that each included native and non-native speakers.
When creating the distance matrix, the average score between each
pair of root words across all raters, non-native, and native English
speakers is used to explore dissimilarity and similarity in categoriza-
tion. Larger distances mean that the scoring categories are more dis-
similar.
Words were clustered with a complete-linkage hierarchical clus-
tering, which can be visually seen in Fig. 10. A Mantel Test was per-
formed to compare the distance matrices of non-native and native
English speakers and to measure the correlation of all entries, with
random permutations calculated to determine the p-value. There was a
correlation of r=0.67 with p < 0.001, suggesting a positive correla-
tion between native and non-native distances. In this preliminary proof-
of-concept analysis, it is clear that primary language is an imperative
factor that should be considered, and has the potential to be in-
formative in linguistics analysis.
Next, the difference between distance matrices of non-native and
native speakers was calculated, and a permutation test on the norm
(sum of all the matrix cells squared) of the matrix of differences was
performed. The obtained p value, the proportion of randomly permuted
norms that are larger than the observed norm, was 0.061. This result is
not significant at type I error 5%, but even with the small sample sizes
within each group, the observed norm is quite large compared to the
distribution of randomly permuted norms and this suggests that the two
distance matrices are quite different. Hence, this further suggests that
primary language may be associated with perceived dissimilarities be-
tween words. An increased sample size is needed to confirm this asso-
ciation.
A strength of the two distinct analyses described above (i.e., in-
tensity rating and categorization of words) is that universal principles
could be further developed, tested, and validated that would allow
quantification of fear and fear-related memories in various populations
of both native and non-native English speakers of diverse cultural
backgrounds around the world. Based on the available data, there is
good reason to believe that the same approach would work well in
children, adults, and the elderly. This would be particularly helpful for
global mental health efforts, as it may be possible to utilize the hier-
archy of fear-related words to further development of fear ratings,
regularly used in CBT-based interventions as a measure of conscious
fear (see the argument for importance of subjective reports of fear and
anxiety, LeDoux and Hofmann, 2018).
Similarly to the predictive nature of future cognitive impairments
discovered in texts analyzed from nuns (Barnes et al., 2003), one can
see how written texts could be used to assess mental health and follow
annual changes in mental health. This has the potential to be especially
insightful for those with challenging assignments, including soldiers
during and following deployment, emergency teams responding to
natural and terrorism-related disasters, astronauts during and following
space missions, and those that are part of populations at increased risk
to develop fear-related disorders. Moreover, this could be valuable for
flagging individuals who might be at increased risk to harm themselves
and/or others. Based on research following shootings or other attacks at
schools and crowded, public events, it is often noted that suspects often
drafted and posted concerning texts in e-mails, web sites, or social
media accounts.
We realize that the basis of the above analyses is the presence of
fear-related words, which is a potential limitation. The absence of fear-
related words will be important to include in the analysis as well,
especially in those who suppress their use because of severe traumatic
memories and attempts to avoid reliving them. The suppression could
be expressed continuously or transiently, as part of a cycle, thus high-
lighting the importance of considering longitudinal analyses to detect
either increases or decreases in the use of fear-related words, which
could be used as part of assessments and treatments. Linguistic analysis
is, therefore, an important factor to consider, just as environment, ex-
periences, and genetic and epigenetic factors related to the suscept-
ibility or resilience to fear-related memories are considered in patients.
Table 3
(A) Non-significant words identified as “low intensity” (rank 1–3) by most
raters. (B) Non-significant words identified as “high intensity” (rank 3–5) by
most raters.
A B
Word Native Non-native Word Native Non-native
nervous 2.17 2.50 serious 3.00 3.70
uneasy 2.17 2.70 superimminent 3.20 3.50
shaky 2.33 3.00 anxiety 3.33 3.60
timid 2.50 2.50 menace 3.50 3.10
security 2.50 3.22 intimidate 3.50 3.20
secure 2.50 3.70 fear 3.50 3.60
recreant 2.60 3.38 scare 3.50 3.90
humanize 2.60 3.83 fright 3.50 4.00
vulnerable 2.67 2.80 trepidation 3.83 3.20
queasy 2.67 3.00 frighten 3.83 4.40
awe 2.67 3.40 dread 4.00 4.30
safe 2.67 3.50 graver 4.17 4.30
worry 2.83 3.00 grievous 4.17 4.30
afraid 3.00 3.10 shock 4.17 4.30
apprehend 3.00 3.20 terror 4.67 4.89
craven 3.00 3.63 terrify 5.00 4.90
horror 5.00 5.00
Table 4
Definition of “distance” between word categories used for statistical analyses,
defined by authors Boutros and Raber.
Safety-
Internal
Safety-
External
Anxiety-
Internal
Anxiety-
External
Fear-
Internal
Fear-
External
Safety-Internal 0 1 2 2.5 3 3.5
Safety-External 1 0 2.5 2 3.5 3
Anxiety-Internal 2 2.5 0 1 2 2.5
Anxiety-External 2.5 2 1 0 2 2.5
Fear-Internal 3 3.5 2 2.5 0 1
Fear-External 3.5 3 2.5 2 1 0
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6.2. How well can the main categories of the linguistics framework and the
feelings related to fear inform the neuroscience of fear learning and memory
in health and disease?
Although an important question to address, it seems premature to
answer it at this point in time. It is still unclear whether the absence –
rather than the presence – of specific words might be more informative
to detect fear learning and memory alterations in health and disease
and how specific use might be altered over time following a traumatic
event. Additionally, it is unclear whether a linguistic approach like this
would work better or worse in children, adolescents, or adults. Finally,
a remaining unknown factor is the feasibility of comparing results from
this approach across distinct languages and cultural settings.
6.3. Are there important cross-cultural issues regarding language and
feelings to consider?
As described above, in the relatively small sample of co-authors on
this paper, we detected a profound difference in the intensity ratings of
the analyzed words in native and non-native English speakers. This
highlights the importance to consider cross-cultural distinctions re-
garding language use. In addition to primary language differences, it is
conceivable that there might be considerable cultural differences in
language use in second- and third-languages that would need to be
explored. It is similarly conceivable that there might be profound dif-
ferences depending whether or not there are severe environmental
challenges (extreme poverty, famine, war or terrorism-prone zones,
environments with increased criminal gang-related activities, etc.). The
developmental perspective might also take into account the differences
in acquisition of fear-related vocabulary among children living in
threatening versus non-threatening environments. In order to grasp the
issues of cultural and environmental settings, we checked whether there
were differences in frequency and variety of fear related words when
9–12 year-old children described their earliest memories in Gaza
(n=110) and in Finland (n=148). We found out that none of the
children in Gaza and only one in Finland used a fear-related word in
their descriptions, although 29% of children in Gaza and 7% in Finland
described an event that was related to a trauma or accident. This ob-
servation shows that the threat of the environment would not be linked
to a differently emerging fear vocabulary among children. On the
contrary, the developmental stage as such could play a role. Among
Finnish adults (19–61 years old), 16% used one or more fear related
word in their description of earliest memory. Interestingly, only 9%
described an event that was related to trauma or accident. This means
that many adults – unlike the children – described an event to contain
feelings of fear, although the event was not objectively threatening (i.e.
“I was living with my parents and my grandmother. I remembered
being very much afraid of going to sleep in the evenings, because there
was a Finnish rug hanging in the wall. The rug was displaying an owl,
which looked very scary in the dim light”). We would need more cross-
cultural data sets to explore whether differences in fear-related lan-
guage use does exist and thus necessary to develop standards for each
cultural/environmental setting. Either way, comparing these analyses
across cultural settings by itself will be important and generate valuable
data for fear-related mental health.
The above described approach and related analyses are based on the
use of the same language in different cultures/environmental settings,
allowing a cross-culture comparative approach. However, this might
not always be feasible. For example, it would not be feasible to easily
compare the use of fear-related language in a population using one
language with that of another language, or a population using various
dialects of the same language, such as British-English and American-
English. The involvement of distinct translations and interpreters would
add too much variability to allow for an easy cross-cultural comparison.
An example of two distinct non-English languages would be studies of
children living in the Gaza strip and Finland described above. Two
Fig. 10. Heat maps representing the complete-linkage hierarchical clustering.
(A) A Mantel Test was performed comparing the distance matrices (middle and
right panels), revealing a correlation coefficient of 0.67 and a p value < 0.001.
Left panel. Heat map of all raters together. Middle panel. Heat map of Native
English speakers only. Right panel. Heat map of non-native English speakers
only.
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examples of native English-speaking cohorts in Australia are the Handy
cohort of university students and a cohort of cancer survivors.
7. Interactions: are there relationships between fear learning and
memory and other topic areas studied as part of the Human
Affectome Project?
Fear learning and memory would be expected to affect most other
topic areas studied as part of the Human Affectome Project. The topic
areas especially expected to be affected are, in no particular order: (1)
attention. Steady-state visually-evoked potentials for example have
been used to demonstrate selective attention to specific imminent
threat during fear (Kastner-Dom et al., 2018). Attention is also im-
portant for expectancy bias in fear (Aue and Okon-Singer, 2015); (2)
happiness. Fear and happiness were shown to increases attentional
flexibility (Storbeck et al., 2018); (3) hedonics. For example, fear
learning affects psychological processes in chronic pain (Nees and
Becker, 2017) and stress might contribute to pain-related fear in
chronic pain (Eisenbruch and Wolf, 2015); (4) motivation. Emotions
affects attention, and motivates actions and behaviors (Tyng et al.,
2017); (5) physiological. Fear learning majorly affects physiology
(Keifer et al., 2015); (6) planning; (7) sadness. Sadness was shown to
facilitate the splitting of attention (Storbeck et al., 2018); (8) self. For
example, increased perceived self-efficacy following verbal persuasion
was shown to facilitate extinction of fear learning (Zlomuzica et al.,
2015); and (9) social. Social fear learning, basically fear learning ac-
quired through social transmission, is being studied in humans and
animals (Debiec and Olsson, 2017).
8. Discussion
8.1. What is the degree of consensus in the area of fear learning and
memory?
“Fear learning and memory” is typically studied using Pavlovian
aversive conditioning procedures. The question of consensus in this
area has to be addressed in terms of two sub-questions: (1) is there
consensus about the definition of fear learning and memory? and (2) to
what degree have empirical findings led to a consistent set of conclu-
sions?
There is currently debate about what “fear” actually means. The
standard position is that fear is a non-subjective brain state controlling
hard-wired and learned behavioral responses to threats in addition to
subjective experiences. The fearful brain state is often said to be
amygdala-centered, as the amygdala is viewed as a hub of fear pro-
cessing controlling behavior, physiology, and subjective experience. A
second position is that fear is an innate subjective state, a feeling of
being in harm's way. This state is also said to crucially involve the
amygdala—danger induces fear in the amygdala, and the amygdala
then controls behavioral and physiological responses. Those who as-
cribe to the first view often write and speak as though they ascribe to
the second view, which has been a source of confusion. A third position
also holds that fear is a subjective experience, but that it is cognitively
assembled in the neocortex rather than an innate, programmed state
programmed in the amygdala. In this view, the amygdala controls be-
havioral and physiological responses elicited by the threat rather than
fear itself. These responses affect the state of fear, but are not one and
the same.
The extent of empirical consensus has emerged as the result of be-
havioral and physiological responses; all three views generally agree
that fear is controlled by the amygdala and related subcortical areas.
However, inconsistencies arise when empirical findings are applied to
clinical problems related to fear and anxiety. For example, efforts to
find new pharmaceutical treatments have assumed subcortical-based
views, often not distinguishing between the subjective and objective
views of subcortical circuits, both of which assume that if there is a
change in behavioral and physiological responses, then fearful experi-
ences will also diminish. The third view predicts that specifically tar-
geting subcortical areas to change behavioral and physiological re-
sponses will not necessarily change subjective feelings, as these are
assembled by neocortical circuits. The failure of the drug discovery
effort is more consistent with this third position, however there is still
more investigation to be done to determine where and how fear
learning and memory occurs and can be manipulated.
8.2. What are the gaps in knowledge in the area of fear learning and
memory?
The largest gap in knowledge in this area of research involves the
conscious experience of fear and its pathological manifestations. People
with fear-related problems have a huge range of symptoms. They ex-
cessively avoid potentially fear-arousing situations, become hyper-vig-
ilant and physiologically aroused when confronted with threats, and
feel afraid often. Clearly, all of these symptoms need to be addressed. It
is possible, given that the related neurocircuitry is somewhat distinct,
that different symptoms might require different treatments.
Pharmaceutical treatments arising from animal studies of behavioral
and physiological responses are probably best suited for changing be-
havioral and physiological responses, but less suited to change human
subjective experience. While these treatments may change the intensity
of the experience, the cognitive structures that support a “fear state of
mind” also needs to be changed, potentially requiring cognitive and
mindfulness-based treatments targeted at feelings.
8.3. To what degree might the linguistic framework be valuable for basic
and translational purposes for the area of fear learning and memory?
As described above, subjective experiences and autobiographies are
valuable for analyzing fear and fear-related memories. Based on that, a
linguistic framework is likely valuable for both basic and translation
purposes. These analyses, for example, would be valuable for long-
itudinal analyses in individuals to track response to behavioral and/or
pharmacological interventions and to assess fear and fear-related
memories in individuals as part of challenging missions, such as deep
space missions of astronauts.
8.4. Why is there a need in using and agreeing upon a common terminology
for feelings and emotions related to fear learning and memory
For practical use of a linguistic approach within and across popu-
lations, it will be critical to use a common terminology for feelings and
emotions related to fear learning and memory. Otherwise, it will be
very hard to compare studies. A common terminology would also be
critical for multi-site behavioral and pharmacological intervention
studies for fear learning and memory disorders.
9. Conclusions: the need for an integrated model of affect that
includes fear and other topic areas studied as part of the Human
Affectome Project.
Once the details are worked out within one topic area, it would be
worthwhile to integrate the model to include other topic areas studied
as part of the Human Affectome Project that are likely related to the
fear topic area, particularly those highlighted in Section 7.
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